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ABSTRACT
Alcohol dependence (AD) is a complex addictive disorder, affecting 5.4% of the
general population during a lifetime (Kessler, 2005) and has a complex heterogenous
phenotype, with behavioral, morphological, and genetic components. Alcohol use can
cause gray matter and white matter tissue damage. The extent of alcoholism’s effect on
brain matter structure in young adults is less known. Assessement of low and high
alcohol dependent individuals was derived from DSM-IV.

FSL based Magnetic

Resonance Imaging (MRI) and quantitative fiber tracking derived from diffusion tensor
imaging (DTI) assessed morphological alterations of 6 gray matter structures involved in
addiction and 10 white matter structures that show connectivity of these structures in 26
low AD and 19 high AD individuals. Candidate SNPs were chosen relating to synaptic
plasticity and myelination (BDNF, NTRK2, NFKB1, MAG, OLIG2) and each individual
was genotyped. Alcohol dependence affected the volumes of the caudate-putamen, the
accumbens, the amygdala and the hippocampus.

The uncinate fasciculus was also

affected by level og AD, showing smaller mean diffusivity (MD), quantified separately
for axial diffusivity (AxD), a marker of axonal intergrity, and radial diffusivity (RD), a
vii

marker of myelin integrity. Exploratory associations of AD, morphological alterations
and SNPs, showed significant correlations and trends, but was not well defined due to a
small subject population. The present research shows evidence that behavioral diseases
are associated with identifiable neuroanatomic alterations, and do form relationships with
specific SNPs. Additional information is needed when studying a specific, yet
multifactorial disease, such as AD, but nonetheless, we advocate the use of neuroimaging
measures in genetic studies.
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CHAPTER 1: INTRODUCTION
1.1

Imaging Genetics (IG)
With the advent of advances in molecular biology, neuroimaging, genetics and

psychopathology, opportunities have arisen to study the interplay of genes, brain and
behavior within a translational framework. This strategy, in use at present, in which
genetic effects on brain function can be explored using neuroimaging, is titled “imaging
genetics” (Viding E et al, 2006). Identifying specific genes that contribute to risk for
illnesses can provide critical information on the causes of these diseases that may lead to
the development of novel diagnostic and therapeutic strategies.
The publication of the reference human genome sequence (Venter et al 2001;
Lander et al 2001) has led to the process of identifying common variations in the
sequences and the impact on the gene and its function and how that variation alters
human biology. Imaging, with its capacity to quantify detailed anatomical structure and
function within human subjects, is a tool for characterizing the functional genetics in
human circuitry. This presents a new specified field for science integrating genes,
endophenotypes and neuroimaging.
Examining this relationship between genes and neural systems was initially called
“Imaging Genetics (IG)” (Hariri, Drabant and Weinberger, 2006).

The essence of

“imaging genetics” rests on two general concepts; the effectiveness in delineating
biological pathways and mechanisms by which individual differences in function emerge
and show a biased risk for a clinical disease; and, application of imaging and genetics to
study the susceptibility and development of the specific pathology in question.

1

In the context of a clinical disease state, genes represent the blueprint that either
directly, or indirectly, in concert with the environment, results in the disease.
Additionally, those same genes offer the ability to identify at-risk individuals and
molecular pathways and mechanisms for treatment. Variations in this blueprint, that
impact gene function, will contribute largely to the resultant complex pathological
disease. In the case of biological diseases, protein coding genes appear to be the only
consistent risk factors that have been identified across populations, accounted for by
inheritance (Moldin and Gottesman, 1997).
Genetic epidemiological studies have examined the relationship between specific
genetic polymorphisms and diseases and have shown unclear results (Malhotra and
Goldman, 1999). There are two reasons for this. First, due to individual variability in
observed behavior and subjectivity of this assessment, it is necessary to have large
sample populations, often exceeding a hundred subjects, to identify even small gene
effects (Glatt and Freimer, 2002). Furthermore, subgroups may exist which obscure the
effects in the broader group (e.g. age, gender, etc). Second, the effects of genes are not
expressed directly at the level of the disease, but are mediated by their molecular and
cellular effects on information processing at the cellular level and more globally, in the
human body.
Genes are directly involved in the function of brain regions related to cognitive
processes, and because of this, functional polymorphisms in genes may be related to the
function of neural systems mediating behavioral outcomes (Figure 1). This approach
utilizes an exploration of specific genes, not the genome, molecular mechanisms and
systems, and pathology of an illness. “Imaging Genetics” is a unique tool by which to
2

explore the functional impact of brain relevant polymorphisms with the idea of then
understanding their impact on the human body or behavior.
Functional imaging methods provide information on the integration and
interaction of specific anatomical regions in large scale spatially distinct networks during
cognitive or behavioral responses. This type of data is essential for understanding the
physiology of information processing at the systemic level, and may be sensitive to
pathological changes seen in individuals with disorders (Gothelf et al, 2005; Hirvonen et
al, 2006; Seidman et al, 2006). Neuroimaging methods are successfully applied to
analyze neurological and psychiatric disorders and there is growing evidence that
addictions are associated with alterations in brain structure and function (Thompson et al,
2004). Neuroimaging techniques require no more than a few minutes, to a couple of
hours, of subject participation to acquire data sets which reflect hundreds of repeated
measures of brain structure (Magnetic Resonance Imaging, MRI) and function
(functional Magnetic Resonance Imaging, fMRI). Most importantly, these techniques,
MRI, fMRI, EEG/ MEG (Electroencephalography/ Magnetoencephalography), PET
(Positron Emission Tomography) are non-invasive and the efficiency allows for the
ability to investigate the specificity of a gene’s influence on multiple brain regions and
systems in a single subject in a single session. The capacity of these techniques is to
produce rapid results of differences in brain structure in vivo for the study of genetic
variation. Taken together, these types of data suggest that markers of brain function may
be more sensitive to subtle genetic variations than overt behavior (Hariri and Weinberger,
2003).

3

The search for genetic loci involved in disorders is hampered by the genetic
complexity of an illness; heterogeneity characterizes AD expression, comorbidity with
other disorders that distort clinical presentation. Genes predispose an individual to a
neurological or psychiatric illness and can be transmitted without expression as a clinical
phenotype. The interest arises in developing endophenotypes, indicators of processes
mediating between genotype and phenotype as an important strategy to deal with the
complications. Endophenotypes are behavioral or physical characteristics that represent
the biological features in the gene to behavior pathway. Specifically, they are markers
that are genetically correlated with disease liability, and can be measured in affected or
unaffected individuals. They provide greater power to localize and identify disease
related quantitative trait loci (QTLs) (Balngero et al, 2003). It maybe possible that genes
act more directly on an endophenotype, more than a clinical classification, and thus, a
study may be more efficient in leading to a candidate gene. Endophenotypes may
provide information about neurochemical pathways leading from the genes to the
clinically diagnosed behavior. Biological endophenotypes are measureable intermediate
phenotypes that are generally closer to the action of the gene (Gottesman and Gould,
2003). Although neurological and psychiatric illnesses are typically identified through
behavioral observation, these illnesses are closely associated with brain structures.
Advances in neuroimaging indicate that particular diseases preferentially disturb specific
neuroanatomic structures. Furthermore, the distribution of structural differences reflects
the underlying pathology. For example, hippocampal/ limbic system atrophy points to
addiction and cerebellar atrophy in Karsokoff’s syndrome points to chronic alcoholism.
These alterations seen in affected individuals often predate overt symptom expression in
4

a less severe form (Fleisher et al, 2005). Previous literature has focused on
electrophysiologic measures that are representative of AD subjects. AD individuals show
evidence of several abnormalities in electrophysiologic functioning including differences
in all three bands of a resting EEG versus controls (Porjesz B et al. 2005). Numerous
additional studies suggest that electrophysiologic endophenotypes can be used as
biological markers and may be utilized in genetic analyses. Biological endophenotypes
are measurable intermediate phenotypes that are generally closer to the action of the gene
(Gottesman and Gould, 2003). In conclusion, findings of neuroanatomical alterations in
affected individuals and with increased genetic risk for the disease suggest that at least a
portion of the indices could be endophenotypic markers (McDonald et al, 2004).
The complete process involves identifying a genetic polymorphism (e.g. single
nucleotide polymorphism, SNP) within a candidate gene, one which has an impact at the
molecular level and has a distribution that involves information pathway in the brain. At
a fundamental level, all three concepts--genetics, neuroimaging and human behavior--are
linearly linked within “imaging genetics.”

IG provides a starting point for further

characterization of molecular and functional effects of candidate genes in brain systems
that are involved in a specific behavior. As such, the contributions of variances in these
systems to complex psychopathologies can be understood from their genetic origins.

5

Figure 1. Integrating behavioral neuroscience and genetics through the intermediate
phenotype approach. (a) Variations in genes can lead to variations in function, yet many
steps exist between. (b) Numerous sub-disciplines study the different links in the causal
chain from gene to behavior. (Green et al, 2008).

6

1.2

Epidemiology of Alcohol Dependence Syndrome (ADS)

1.2.1

Alcohol Dependence Syndrome (ADS)
Alcohol dependence, a common disorder with heterogeneous etiology, as

described in the DSM-IV is a psychiatric diagnosis describing a measure in which an
individual uses alcohol despite significant areas of dysfunction, evidence of physical
dependence, and/or related hardship. Alcohol dependence is acknowledged by the
American Medical Association as a disease with a characteristic set of signs and
symptoms with a progressive course.

For a person to meet criteria for Alcohol

Dependence (OMIM #103780) within the criteria listed in the DSM-IV, they must meet 3
of a total 7 possible criteria within a 12-month period.
The first 2 criteria are related to physiological dependence: tolerance and
withdrawal. The 3rd and 4th criteria establish a pattern of losing control of drinking by
breaking drinking rules or failing at attempts to quit or cut back. The 5th and 6th criteria
are indicative of a progression of addiction as more and more time is spent on drinking
and changes in lifestyle result. The seventh criterion for Alcohol Dependence is met
when a person continues to drink despite being aware that their drinking is causing or
exacerbating some psychological or physiological problem(s).
Alcohol Dependence is differentiated from alcohol abuse by the presence of
symptoms such as tolerance and withdrawal. Both alcohol dependence and alcohol abuse
are sometimes referred to by the less specific term “Alcoholism.” Alcohol dependence
syndrome (ADS) is a classification of alcoholism proposed by Edwards and Gross in
1976 and formally defined by the World Health Organization. This system standardizes
terminology and differentiates between two disorders: alcohol abuse, disabilities that
7

result from excessive drinking, and alcohol dependence, tolerance and withdrawal
(Figure 2). Alcohol dependence refers to alcohol as an addictive agent and remission, as
defined within DSM-IV, and the measure can be attained despite continued use of
alcohol. That is, a patient can be in sustained remission yet still be drinking alcohol so
long as the patient does not meet the 3 out of 7 criteria.
The alcohol dependence syndrome is seen as a cluster of seven elements and not
all elements may be present in each individual case, but the diagnosis is sufficiently
consistent and coherent to be recognized clinically. Also, the syndrome exists in degrees
of severity rather than a categorical absolute. Thus, the question is not ‘whether a person
is dependent on alcohol’, but ‘how far along the scale of dependence has a person
progressed.’

8

Figure 2. Differentiation of alcohol dependence syndrome from alcohol related
disabilities (Skinner and Allen, 1982).

1.2.2

Alcohol Dependence Syndrome: Diagnosis
The ADS scale provides a quantitative measure of the severity of alcohol

dependence consistent with the concept of the alcohol dependence syndrome. The printed
instructions for the ADS refer to the past 12-month period. However, instructions can be
altered for use as an outcome measure at selected intervals (e.g., 6, 12, or 24 months)
9

following treatment. ADS scores have proven to be highly diagnostic with respect to a
DSM diagnosis of alcohol dependence, and have been found to have excellent predictive
value with respect to a DSM-IV diagnosis. The ADS is used in wide variety of settings
for screening and assessment of alcohol dependence. Several studies have used the ADS
with adolescents. The ADS can be used for screening and case finding in a variety of
settings including health care, corrections, general population surveys, workplace, and
education. A score of 9 or more is highly predictive of DSM diagnosis of alcohol
dependence.
In 1981, Skinner identified an Alcohol Dependence Factor that correlated with
chronic social debilitation and psychopathology, deriving a 29-item Alcohol Dependence
Scale.

Skinner and Allen’s study in 1982 found that the dependence syndrome is

assessed reliably (internal consistency=0.92) with a brief self-report scale and that the
syndrome correlates in predictable ways with clinic attendance, physical symptoms and
psychosocial problems in the subject’s life.

The 29 items that form the ADS

questionnaire encompass four key aspects of the syndrome: (1) loss of behavioral control
(i.e. blackouts, gulping drinks) (2) psychoperceptual withdrawal symptoms (i.e.
hallucinations) (3) psychophysical withdrawal symptoms (i.e. hangovers, deliriums
tremens), and (4) obsessive-compulsive drinking style (i.e. sneak drinks, hidden drinks,
drink availability). The advantage of using the AD Scale is that it may be used to order
individuals along a continuum of alcohol dependence rather than make a discrete
diagnosis of alcoholic and non-alcoholic (Skinner and Allen, 1982). The following
elements are the template for which the degree of dependence is judged:

10

1. Narrowing of the drinking repertoire.
2. Increased salience for alcohol over other competing responsibilities.
3. An acquired tolerance to alcohol.
4. Withdrawal symptoms.
5. Relief or avoidance of withdrawal symptoms by further drinking.
6. Subjective awareness of compulsion to drink.
7. Reinstatement after abstinence.
Specifically, the high correlation between alcohol dependence and adverse
consequences from drinking demonstrated that the Alcohol Dependence Scale provides
the proper information for defining levels of dependence. The ADS can be used for basic
research studies where a quantitative index is required regarding the severity of alcohol
dependence. For clinical research, the ADS scale is a useful screening and case-finding
tool.
1.2.3

ADS: Incidence in the human population
Alcohol dependence is a widespread disorder, affecting about 10% of the

population (Sher et al, 2005). Approximately 5-7% of the adult U.S. population is
diagnosed with alcohol dependence, a complex addiction having a heritability of at least
50% in both men and women (Reich et al, 1998). About 12% of American adults have
had an alcohol dependence problem at some time in their life (Hasin et al, 2007). From
the estimated 27 million Americans exhibiting AUD--alcohol abuse or alcohol
dependence—the average age of onset is 22 years and 72% of this population has one 2-5
year-long episode (Hasin et al, 2007).
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1.2.4

ADS: Genetic Associations
Vulnerability to alcohol dependence is most likely caused by multiple interacting

genes, each contributing to the phenotype and symptoms of addictions or brain damage.
AD is essentially a behavioral disorder in nature and the etiology is likely to involve
dysfunction in brain systems; therefore, genes encoding neural substrates mediating these
dysfunctions represent the most obvious susceptibility genes. In particular, the brain
systems involved in the motivational aspects of addiction are considered to be disrupted
sufficiently to produce the characteristic loss of control of consumption and drug seeking.
Crabb et al. in 1990 reviewed biologic markers for increased risk of alcoholism
and concluded that liability to alcoholism is controlled by a major effect with or without
additional multifactorial effects. Twin, adoption and family studies have shown that
genetic factors play a considerable role for risk and symptoms of alcohol dependence
(Goodwin, 1975). Alcohol use leads to addiction, dependence, or tolerance and these
phenomena create adaptive responses at the cellular level so that if the drug is removed,
the neuroadaptations are revealed, leading to manifestation of withdrawal symptoms
(Figure 3). Again, AD is differentiated from alcohol abuse by the presence of symptoms
such as tolerance and withdrawal. In the case of AD, withdrawal is the presentation of
symptoms (e.g. agitation, delirium tremens, depression, seizures and death) that occur
upon the abrupt discontinuation/separation or a decrease in dosage of alcohol.
Substantial evidence suggests that this cellular adaptive process is mediated, at least in
part, by changes in gene expression (Nestler et al., 1994). Morphometric studies of gray
matter suggest that neurons in the frontal lobe are selectively damaged (Kril and Harper,
1989) and thus, the frontal cortices, important in judgment, decision-making, and other
12

executive functions (Rahman et al, 1999) have been chosen as a focus for addiction and
alcoholism. Lewohol et al in 2000 selected this region from post-mortem tissue of
alcoholic individuals for DNA microarray analysis. This analysis revealed expression
levels of 400 genes of which 163 were found to differ by 40% or more between alcoholic
and non-alcoholic individuals.

Specifically, a significant decrease in myelin-related

genes, PLP, MAG, Mal, and MBP, in the frontal cortex indicated that alcohol abuse
directly or indirectly affects the transcription of these proteins. Hill et al (2004) studied
families containing 330 alcoholic individuals identified, through multipoint linkage
analyses, loci on chromosomes 1, 2, 6, 7, 10, 12, 14, 16, and 17. Several linkage studies
give evidence for many chromosomal loci, where--among others--glutamatergic and
dopaminergic genes are located (Edenberg and Foroud, 2006).

Genetic association

studies that have shown a relationship between alcohol dependence and numerous
neurochemical/neurotransmitter systems and neuroimaging studies provide further
support for the role of alterations in these systems in the pathogenesis of alcohol
dependence (Wong et al., 2003).
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Figure 3. Model illustrating influences on genetic factors on the development of AD.
Some of the proposed genetics factors have a disorder specific influence (Dick and
Agarwal, 2008).

1.2.5

Alcoholism and Depression
The Collaborative Study on Genetics of Alcoholism (COGA) identifies genes

contributing to alcoholism and related traits, including depression. Psychopathological
studies have observed that alcoholism and affective disorders interact and can coexist; the
vulnerability to both alcoholism and depression can run in families (Merikangas and
Gelernter, 1990; Merikangas et al., 1994). In 2002, Nurnberger et al, defined three
phenotypes- “alcoholism”, “alcoholism and depression,” and “alcoholism or depression”and analyzed whether these phenotypes were linked to specific chromosomal regions.
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The analysis found a genetic linkage to an area on chromosome 1 suggesting that a gene
or genes in this area may predispose individuals to alcoholism and depression that may be
alcohol induced. Alcoholism and depression tend to occur together in families where
both disorders are transmitted. The limitation of this study is that by design it focused on
familial linkage analysis and did not represent the spectrum of people who are AD,
depression or both.
1.3

Neuro-Imaging Techniques for Neuroanatomical Studies

1.3.1

History of Neuroimaging: AD
Chronic alcoholism has been associated with global changes in brain morphology,

such as cortical and sub-cortical atrophy. The first documented case of damage due to
chronic alcoholism, using pneumoencephalography (Brewer and Perrett, 1971) showed
brain shrinkage and was easily confirmed using CT scans of heavy drinkers and
alcoholics (Cala et al., 1985). Postmortem study of alcoholic subjects has identified
damage in white matter and identified demyelination (Lewohl et al., 2000), microtubule
disruption (Paula-Barbosa and Tavares, 1985) and axonal deletion, as well as
morphological degeneration involving cell processes (Harper et al., 1987). Also, volume
reduction arising from shrinkage, reduction in cell counts, size, or neuronal processes has
been reported (De la Monte, 1988; Harper and Kril, 1990, 1991). Although, these studies
have been essential in identifying gross neuroanatomical damage in alcoholism, the postmortem fixation process and collapse of certain regions, does not reflect the alcoholrelated effects on the living brain (Pfefferbaum et al., 2004). In vivo conventional
magnetic resonance imaging (MRI) studies have provided convergent validity for the
damage observed in alcoholic subjects post-mortem and are generally consistent with the
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neuropathological literature regarding white matter volume reduction in the cerebrum
(Pfefferbaum et al, 1992).
1.3.2

Magnetic Resonance Imaging (MRI): Physics
The brain is mainly composed of water molecules and when an individual is

placed within a powerful magnetic field of the scanner (a diffusion–weighted pulse
sequence) these protons align with the direction of the field. A second radiofrequency
electromagnetic field is then briefly turned on causing the protons to absorb some of its
energy. When this field is turned off the protons release the obtained energy at a
radiofrequency that is detected by the scanner. The position of protons in the body can be
determined by applying additional magnetic fields during the scan that allow an image of
the brain to be constructed, slice by slice. Diseased or damaged tissues, such as tumors
or plaques, are detected due to the different rates of reaching equilibrium states for all the
protons in the region of interest (ROI). By changing the parameters on the scanner, using
additional magnetic fields, a contrast between different tissues is created (Lauterbur et al.,
1989, Figure 4). MRI uses no ionizing radiation and is generally a very safe procedure.
Figure 4. Relationship between a 3D object and
its 2D projection along the y-axis and four 1D
projections at 45deg intervals in the xz-plane.
The arrows indicate the gradient directions
(Lauterbur PC, 1989).
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1.3.3

Diffusion Tensor Imaging (DTI): Physics
Structural MRI enables quantification of bulk volume and a few aspects of tissue

quality but does not assess the microstructure of brain tissue and its components, such as
axons, microtubules, and myelin. By contrast, diffusion tensor imaging (DTI) permits in
vivo quantification of the directionality, coherence and microstructural integrity of white
matter tracts (Moseley et al., 1990; for reviews on method and application in human
studies see Basser and Jones, 2002; Kubicki et al., 2002; Sullivan and Pfefferbaum,
2005).
The intrinsic property of water diffusion in human brain tissue provides
information about the structural characteristics of the tissue. When the diffusion of water
molecules is unconstrained (e.g. CSF), it is characterized by Brownian motion. The
resulting molecular displacement produces a Gaussian distribution where the movement
has no directional preference and is, therefore, “isotropic.” When motion is restricted by
boundaries with a predominant direction, such as the walls of a white matter tract, the
diffusion is greater in parallel to the tract and thus is “anisotropic” (Figure 5A). White
matter is highly organized in fiber bundles that restrict water and so, the orientation of the
diffusion depends on the orientation of the specific fiber tracts observed. The axon’s
cytoskeleton consists of axoplasm and organelles, and this includes neurofilaments,
mitochondria, and microtubules.

The axon bundles are organized as fasciculi,

commissures, and fibers linking brain regions. With disease or trauma, the cytoskeleton
that has high anisotropy in healthy white matter, is disturbed and results in lower
anisotropy (Arfanakis et al., 2002). In addition to this extracellular spaces between fibers
will sequester fluid and provide space for water movement, also contributing to
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anisotropy. Anisotropy is calculated in a within voxel basis and is expressed as a
fraction—fractional anisotropy (FA) for a ROI (Pierpaoli and Basser, 1996). The way to
conceptualize the information on FA is to view it geometrically (see Figure 5C). The
tensor effectively fits the angular variation of the diffusion direction values to the shape
of a 3D ellipsoid.

Anisotropic diffusion within white matter is modeled with an

elongated ellipsoid, indicating directionality of the water molecules. The 3 directions of
eigenvectors are diagonalized and averaged to obtain the FA value (Mukherjee P et al,
2008). A tract or structure with high FA is indicative of restricted diffusion typically in a
normal organized tissue. The FA of CSF is near 0 and can approach a value of 1 in the
corpus callosum. DTI studies in alcoholism are revealing abnormally low FA in white
matter brain structures, in particular the corpus callosum, implying damage to fiber/tract
structure (Figure 6).
In DTI, water diffusion, meaning the thermal motion of water molecules is also
measured. The diffusion constant relates to the average displacement of a molecule over
an area to the observations of time. The mean diffusivity (MD) is the diffusion constant
measured in a clinical state, reflecting the limitation that in vivo diffusion cannot be
separated from other sources of water mobility, such as active transport, flow along
pressure gradients and changes in membrane permeability (Mukherjee P et al, 2008).
Therefore, MD is characterized by the overall mean-squared displacement of molecules
(average ellipsoid size) and the overall presence of obstacles to diffusion, where each of
the three axes ADCx, ADCy, ADCz and the average diffusivity is (ADCx + ADCy +
ADCz)/3=MD White matter tracts with tightly packed coherently oriented fiber bundles
hinder water displacement perpendicular to the direction of the fibers, resulting in larger
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apparent diffusion coefficient (ADCx) values parallel to the tracts rather than orthogonal
to them (Chenevert TL et al, 1990). In the healthy human brain the MD in white matter
is 0.64-0.71 x 10-3 mm2/s and a variable rate of decline in the MD value reflect speed of
growth, maturation and an increase in axonal integrity (Mukherjee et al, 2001; Hermoye
L et al, 2006). The conventional explanation for reduced MD is membrane permeability
changes, better axonal integrity, cellular swelling and decreased volume but increased
tortuosity of the extracellular space (Duong et al, 1998). Reduction of radial diffusivity
may be attributed to myelination as this modulates the diffusion anisotropy originating
from cell membranes by creating an additional barrier (Beaulieu, 2002). Furthermore, the
lack/disruption of myelin sheath has been found to increase radial diffusivity without
affecting axial diffusivity (Song et al., 2002).
The primary eigenvector is important for WM tracking because this vector
indicates the orientation of the axonal fiber bundles. Therefore, it is also known as “axial
diffusivity” (AxD) and is specifies the rate of diffusion along the orientation of the fibers.
The second and third eigenvectors are orthogonal to the primary eigenvector, and their
associated values give the magnitude of diffusion in the plane transverse to the axonal
bundles. Hence, the mean of these two eigenvectors is also known as “radial diffusivity”
(RD).
Structural brain imaging has provided clear evidence that long-term consumption
of alcohol is associated with reductions in brain volume but fails to provide evidence of a
connection to vulnerability of these tissues to damage. DTI can therefore provide visual
depictions of white matter fiber systems, which can be measured with quantitative fiber
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tracking. The advantage of quantitative fiber tracking is that DTI metrics are derived
only from fibers identified in a region of interest.

C. Diffusion Ellipsoids and Tensors

Figure 5. Isotropic and anisotropic diffusion. (A) Motion is unconstrained, i.e. the
ventricles, diffusion is isotropic, meaning motion occurs equally and randomly in all
directions. (B) Motion is constrained, i.e. white matter tracts, diffusion is anisotropic,
meaning that motion is oriented more in one direction than another (Rosenbloom et al,
2003). (C) The diffusion ellipsoids and tensors for isotropic unrestricted diffusion,
isotropic restricted diffusion, and anisotropic restricted diffusion (Mukherjee P et al,
2008).
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Figure 6. Coronal images display the MRI and DTI studies of a healthy man (upper) and
age-matched alcoholic subject (lower). The MRI shows a thinner corpus callosum
displaced upward by enlarged ventricles and on the DTI less delineation of white matter
tracts in the alcoholic subject is visible (Pfefferbaum and Sullivan, 2003).

1.3.4

Neuroanatomical Damage in AD: Gray Matter
Neuroimaging has enabled longitudinal study of the examination of alcoholism’s

course through periods of drinking.

Controlled studies have revealed evidence of

alcohol-related brain structural and functional modifications—some permanent, some
transient and some compensatory. In 1975, Tarter and colleagues suggested that
prolonged alcohol abuse results in effects that are most pronounced in the anterior region
of the brain, extending from the frontal lobe through the dorso-medial nucleus of the
thalamus and associated basal regions. Both cortical gray matter (Fein et al, 2002) and
white matter sustain widespread loss (Pfefferbaum et al, 1992). Alcohol-related volume
deficits observed in the frontal lobes (Pfefferbaum et al, 1997), anterior hippocampus
(Sullivan et al, 1995; Agartz et al, 1999), mammillary bodies and cerebellum (Shear et al,
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1996), and corpus callosum (Hommer et al., 1996; Pfefferbaum et al., 1996). In this
section I will provide a brief summary of the major findings for these brain regions.
The prefrontal cortex is the most complex and highly developed of the neocortical
regions in the human brain. It functions as a massive association cortex with afferent and
efferent connections to all other neocortical regions, as well as to the cingulate, limbic
system and the basal ganglia. In 1998, Pfefferbaum and colleagues showed, in a 5-year
longitudinal study, brain volume shrinkage in prefrontal cortex with additional loss in the
anterior superior temporal cortex and lateral and third ventricle enlargement in alcoholics.
Neuropsychological studies have reported selective alterations of frontal executive
functions, such as planning or problem-solving ability, in neurologically normal alcoholic
patients (Pishkin et al., 1985). Moderate neuronal loss has been reported in the frontal
cortex and in the cingulate gyrus of alcoholic subjects (Kril and Harper, 1989).
Quantitative morphometric studies show brain volume shrinkage that relates to a
reduction in the volume of the white matter in the cerebral hemispheres rather than
volume changes in the cerebral cortex. Harper et al (1985) showed a mean reduction of
4.6% in white matter volume, and de la Monte (1988) found a 6.1% to 17.5% reduction.
Major areas of the limbic system include the hypothalamus, amygdala,
hippocampus, septal nuclei, and anterior cingulate gyrus. Functions of the limbic system
include mediating learning and memory and contributing to emotions. These regions
have essential roles in alcoholism (see Figure 7).
The amygdala (AMG) is a small almond-shaped structure deep inside the anteroinferior region of the temporal lobe that is partially controlled by the brain's dopamine
system (Salgado-Pineda et al., 2005), and is an essential part of the brain’s reward and
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emotion circuitry. It is a heterogeneous brain area consisting of 13 nuclei and cortical
regions and their subdivisions.

The amygdala connects with prefrontal cortex, the

hippocampus, the septal nuclei, and the medial dorsal nucleus of the thalamus. This
system responds to alcohol and produces feelings of pleasure when positive
reinforcement occurs (Koob, 2003). Koob, 2003 describes that neuropharmacologic
studies in animal models have provided evidence for neurochemical mechanisms in
specific brain reward and stress circuits that become dysregulated during the
development of alcohol dependence. There are multiple neurotransmitter systems that
converge on the extended amygdala that become dysregulated during the development of
alcohol dependence, including gamma-aminobutyric acid, opioid peptides, glutamate,
serotonin, and dopamine. In addition, the brain stress systems may contribute
significantly to the allostatic state. During the development of alcohol dependence,
corticotropin-releasing factor may be recruited, and the neuropeptide Y brain antistress
system may be compromised. These changes in the reward and stress systems are
hypothesized to maintain hedonic stability in an allostatic state, as opposed to a
homeostatic state, and as such convey the vulnerability for relapse in recovering
alcoholics. It is well known that excessive chronic drinking is accompanied by a broad
spectrum of emotional changes ranging from apathy and emotional flatness to deficits in
comprehending emotional information, but their neural bases are poorly understood. In a
recent study using fMRI, Marinkovic et al, 2009, observed clear evidence of differences
between abstinent long-term alcoholics and non-alcoholic controls in amygdala activation
to emotional materials, suggesting that the amygdala can control or affect the outcome of
addiction to alcohol.
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The hippocampus (HPC) is a three-layer sheet of neurons located on the floor of
each lateral ventricle within the temporal lobes and adjacent to the amygdala. As part of
the limbic system, it is involved in motivation and plays a central role in memory
formation (Ramsey et al, 2002). The HPC consists of interfolded layers of the dentate
gyrus and cornus ammonis, which is continuous with the subiculum, which in turn
merges with the parahippocampal gyrus. It is a well-known fact that alcohol is a
teratogen affecting the hippocampal development and function Structural neuroimaging
studies have demonstrated a reduction of hippocampal volume in alcoholics (Agartz et al,
1999; Pfefferbaum and Sullivan, 2002). One study demonstrated hippocampal volume
reduction in heavy, chronically drinking, alcohol dependent subjects compared with nonalcoholic controls (Makris et al, 2008, see Figure 8). In 1997, Harding et al showed the
loss of hippocampal volume in humans and attributed it to changes in white matter and in
2002, Roberto et al, showed that chronic alcoholism in the rat, significantly impairs
hippocampal long term potentiation.
The thalamus serves as a major junctional complex that modulates input to the
PFC (Nauta, 1971, 1972). Volume shrinkage in the thalamus (Sullivan et al, 2003),
caudate and putamen occurs in alcoholics. Sullivan et al (2003) has also observed
significant volume shrinkage in the nucleus accumbens of recently drinking alcoholics
relative to subjects that were sober for a month.
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Figure 7. Cross section of the human brain. Cortical, limbic, and cerebellar regions are
highly vulnerable to alcoholism damage. Among the regions discussed presently are the
amygdala, hippocampus, and thalamus (Oscar-Berman and Bowirrat, 2005).

Figure 8. The hippocampus and amygdala are shown as 3D isosurfaces. The average
shape of the HPC and AMG of control subjects is coregistered and superimposed on the
average shape of these structures in the subjects with alcoholism. As seen in the figure
there is a more pronounced volume reduction in the left amygdala (Makris N et al.,
2008).
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1.3.5

Neuroanatomical Damage in AD: White Matter Tracts and Bundles
Structural MRI studies have shown that white matter subadjacent to the cortex,

corpus callosum (Hommer D et al., 1996; Pfefferbaum A et al., 2006; Estruch R et al.,
1997), and pons (Sullivan EV et al. 2001, 2006) is affected in terms of macrostructural
volume deficits in uncomplicated alcoholism. MRI studies also show thinning of the
corpus callosum in older alcoholic men (Pfefferbaum et al., 1996) and a higher incidence
of large white matter hyperintensities (WMHIs) than matched controls (Jernigan et al,
1991; Pfefferbaum et al., 1992). WMHI can reflect several processes—including edema,
demyelination, gliosis or excess cerebro spinal fluid (CSF). MRI studies have reported
that the greatest cortical and sub-adjacent white matter loss occurs in the frontal lobes
(Pfefferbaum et al., 1997). Initial studies using DTI in uncomplicated alcoholism have
reported abnormally low anisotropy in regionally defined white matter of alcoholic men
(Pfefferbaum et al., 2000) and women (Pfefferbaum and Sullivan, 2002). In these studies
both men and women showed deficits in the callosal genu and centrum semiovale, and
men showed additional deficits in the callosal splenium (see Figure 9). The damage of
the cerebral cortex in chronic alcoholism also results in corpus callosum atrophy with a
decrease in area, thickness of genu, and splenium (Oishi et al., 1999). The corpus
callosum is reduced in thickness in alcoholics when compared to age- and sex- matched
controls (Harper and Kril, 1988; Pfefferbaum et al., 2000). A survey of multiple brain
fiber systems revealed a differential pattern of alcoholism’s effect on regional FA with
functional consequences attributable in part to compromised fiber microstructure with
signs of myelin degradation (Pfefferbaum, et al., 2008). In Pfefferbaum’s 2008 study 11
major white matter bundles were assessed using DTI in 87 alcoholics and 88 healthy
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controls. Alcoholism affected FA and MD of several fiber bundles including the frontal
forceps, internal and external capsules, fornix, and superior, cingulate and longitudinal
fasiculi. In conclusion, these previous studies and results indicating an interruption of
intra- and inter- voxel coherence of white matter tracts provides in vivo evidence that
alcoholism disrupts white matter microstructure.

Figure 9. White matter damage. (A) T1-weighted image of MRI in a chronic alcoholic
(>83ml alcohol consumption everyday for 10 years) and a healthy control (Oishi M et al.
1999). (B) Alcoholic subjects, men and women, have lower fractional anisotropy (FA) in
the genu of the corpus callosum, the centrum semiovale. Male subjects also have a lower
FA for the splenium. (Rosenbloom MA et al., 2003).

1.4

Genetics and Alcohol Dependence

1.4.1

Genetics: Alcoholism and Candidate Genes
Genes are the biological toolbox with which one negotiates the environment

(Hariri and Weinberger, 2003).

Numerous questions come to mind with such a

statement: How does a gene affect brain structure and information processing with regard
to certain personality traits or cognitive abilities, and how does it increase risk for a
neuropsychiatric disorder? How many genes contribute to a particular complex behavior,
clinical symptom, or disease? What genetic overlap exists across behaviors, symptoms
and diseases? How large are the effects of candidate genes on particular brain functions?
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The "candidate gene association" approach has been a popular strategy for
attempting to answer all of the questions above. Genetic associations are a test of a
relationship between a particular phenotype and a specific allele of a gene.

This

approach begins with a selecting of biological aspect of a particular condition or disease,
then identifying the variants in genes thought to impact the candidate biological process,
and next searching for evidence that the frequency of a particular variant is increased in
populations having the disease or condition. A significant increase in allele frequency in
the selected population is evidence of an association.

When a particular allele is

significantly associated with a particular phenotype, it is potentially a causative factor in
determining that phenotype. There are, however, caveats to the design and interpretation
of the association studies.

Among them are linkage disequilibrium, ancestral

stratification and whether a particular genetic variation observed is of major relevance to
a distinct human condition. (Glabus, 1994)
1.4.2 Strategies for Gene Identification in AD
Molecular genetic techniques were defined by the introduction of polymerase
chain reaction (PCR) in 1983 (Saiki, et al, 1988) which replicated and analyzed DNA
sequences and their structure. Specific stretches of DNA that are closely linked to the
genes that underlie the trait in question identifies Quantitative Trait Loci (QTLs) and
alleles, individual variations of DNA in a distinct region, constitutes a polymorphism.
Polymorphisms are used for genetic analysis: DNA sequences in non-coding DNA
regions with repeats that vary in frequency are microsatellite markers. The exchange of
single nucleotides in the DNA is the origin of single nucleotide polymorphisms (SNPs)
that are found in coding or non-coding DNA.
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There are numerous and sufficient experimental ways of combining molecular
methods and the epidemiological data to detect the contribution of genes to AD- linkage
studies and association studies.
Quantitative Trait Loci
Inheritance of a phenotypic characteristic that varies in degree and can be
attributed to the interactions between two or more genes and their environment are
quantitative trait loci (QTLs) or stretches of DNA that are closely linked to the genes that
underlie the trait in question. QTLs can be molecularly identified to help map regions of
the genome that contain genes involved in specifying a quantitative trait. Initially, a QTL
is localized by a genomic scan to a large chromosomal region. The localization is done
by linkage analysis using population data on the co-segregation of phenotypes in
families. After a QTL is localized to a specific region that chromosomal region is finely
mapped and saturated with additional genetic markers.
Genetic analysis of brain structure is complex, involving genetic and
environmental components and interactions. Recent studies have pointed to specific
genes that have significant influence on variation in the human brain (Evans et al, 2005)
but the significance is not quantified.
Single Nucleotide Polymorphisms
A SNP (“snip”) is a source of variance in a genome caused by a single base
mutation in the DNA sequence. It is the most simple form and most common source of
genetic polymorphisms in the human genome (90% of all human DNA polymorphisms).
Specifically, there are two types of nucleotide base substitutions resulting in SNPs; a
transition substitution that occurs between purines (A, G) or between pyrimidines (C, T)
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which constitutes two thirds of all SNPs; and a transversion substitution that occurs
between a purine and a pyrimidine. SNPs are not uniformly distributed over the entire
human genome, neither over all chromosomes and neither within a single chromosome.
There are one third as many SNPs within coding regions as non-coding region SNPs. A
SNP in a coding region may have two different effects on the resulting protein either a
synonymous/silent mutation or non-synonymous substitution in the amino acid sequence.
A SNP in the genetic profile are labeled as the frequent allele (A/A), the heterozygous
allele (A/B) or the rare allele (B/B).
In this causal chain from gene to protein to mental function, brain activity is the
likely key intermediary that can help bridge the gap between genes and behavior.

As

mentioned above, a polymorphic site in a gene can encode different gene products and
these proteins may function differently, a SNP can have a direct effect on the function of
the gene in which it is located. A variant may result in an amino acid change or may alter
exon-intron splicing, thereby directly modifying the relevant protein, or it may exist in a
regulatory region, altering the level of expression or the stability of the mRNA. This
difference in molecular function could be reflected in different levels of localizations of
neural activity during a particular disease state, in this case alcohol dependence; these can
be measured using neuroimaging techniques and quantified as morphological changes in
structure and function. In particular, a relationship between genetic variation and a brainbased phenotype in the absence of a brain-behavior association can be informative. This
sort of finding can identify genetic differences on neural processes (efficiency of tracts)
that cannot otherwise be observed directly. Overall, it is estimated that each person is
heterozygous for 24,000 –40,000 substitutions that alter amino acid (Cargill et al, 1999).
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These variants are likely to occur as rare alleles (Sunyaev et al, 2000), with most nonsynonymous coding region SNPs having allele frequencies below 5% (Halushka et al,
1999). But there are non-synonymous coding region SNPs that are both common and
associated with diseases. This relation forms the basis and motivation for the
identification and genotyping of SNPs, which forms the foundation for linkage and
association studies described below.
Linkage Studies
The genomes of all individuals within a family of affected members are scanned
and multiple microsatellite markers or SNPs that may be associated with a specific
disease through out all chromosomes. If the tested markers are in close in proximity to
the gene of relevance to the disease, affected siblings are expected to share more identical
alleles, resulting in a “marker” for the disease. Parametric, for monogenetic diseases, and
non-parametric, for complex diseases such as AD, statistical analysis tests can be used to
evaluate a significant linkage between the gene and disease. The advantage is that
linkage studies can be used to systematically screen the entire genome.
Association Studies
This study design aims to analyze whether a single gene and its polymorphic
structure affects the specific disease involving a sampling strategy of unrelated
individuals. These tests are dependent on the sequence variant in question having a true
functional effect on the phenotype, or being in linkage disequilibrium (LD) with a
functional variant. Here, LD represents the statistical correlation between two sequence
variants due to a shared history and, thus, is a stochastic phenomenon. The candidate
gene analysis tests if certain alleles of the gene are associated to a disease, a trait or
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endophenotype.

A “candidate gene” is one whose function is related to the

pathophysiology of the disease, or the gene lies in a chromosomal region that has already
been linked to the disorder by linkage analysis (Dick DM and Foroud T, 2002). In the
pathophysiology of AD multiple neurotransmitter systems are involved and thus
numerous genes are stated as candidate genes. For further analysis a population based
study is chosen. In this case the polymorphisms of two defined groups are compared
with each other. In the genetic research of AD these two groups could include a low AD
in one group versus high AD in the other. With multiple genes are involved in the
pathogenesis of AD and the effects of a single gene are more than likely to be small, large
sample sizes are needed to detect such genes.
Association studies of quantitative endophenotypes, like neuroimaging measures,
usually involve simple tests for differences in means between marker genotypes, typically
a SNP (Glahn et al, 2007).
1.4.3 Identified Candidate Genes in AD
Despite the complications mentioned in identifying genes involved in complex
disorders, recent progress has identified specific genes involved in the predisposition to
AD (see Figure 10). In 2007, Rodd and colleagues used a comprehensive translational
approach for identifying candidate genes for alcoholism. The approach cross-matched
animal model brain gene expression data with human genetic linkage data, as well as
human tissue data and biological roles data, a method called convergent functional
genomics (CFG). A comprehensive microarray analysis of gene expression data from
five brain regions (frontal cortex, amygdala, caudate-putamen, nucleus accumbens and
hippocampus) revealed identification of high probability candidate genes, pathways and
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mechanisms for alcoholism (see Figure 11). Specifically, the data revealed that alcohol
has pleiotropic effects on multiple systems.

Pleiotropy occurs when a single gene

influences multiple phenotypic traits and a new mutation in the gene may have an effect
on some or all traits simultaneously. Consequently, a new mutation in the candidate gene
may have an effect on some or all traits simultaneously. Pathways identified by Rodd et
al included cell adhesion signaling, iron-heme metabolism, cardiovascular regulation,
stress response, and cell proliferation. SNPs that have consistently associated with AD
are polymorphisms in the alcohol metabolizing enzymes such as the alcohol
dehydrogenase (ADH) class I isozymes (Shen et al, 1997).
Several lines of evidence also implicate γ-aminobutyric acid (GABA), the major
inhibitory neurotransmitter in the central nervous system, is involved in many if the
behavioral effects of alcohol, including withdrawal signs and ethanol preference (Grobin
et al., 1998).

Most of the GABAA receptor genes are organized into clusters on

chromosomes 4, 5 and 15 and have emerged from numerous genome wide linkage scans
of AD (Long et al., 1998; Covault, et al., 2004). Specifically, a systematic investigation
of markers identified a significant association of multiple SNPs between a cluster on
chromosome 4 and alcohol dependence and it’s electrophysiologic endophenotype
(Edenberg et al, 2005).
Opioidergic neurotransmission has been implicated in the reinforcing effects of
several drugs of abuse, including AD (Dick and Bierut, 2006). Specifically, the gene
coding for the opioid receptor (OPRM1) displays functional polymorphisms and a
number of studies have reported an association between OPRM1 and substance
dependence (Wagner et al., 2004).
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Another gene recently implicated in association with alcoholism is a cholinergic
muscarinic receptor, CHRM2, pointing to a region on chromosome 7 when identified
during linkage analysis. An association with CHRM2 was also observed with
electrophysiologic endophenotypes, an example of how endophenotypes lead to gene
identification and associate to a diagnosis.
The dopamine system is known to play an important role in reward behavior and
the effects of alcohol are mediated through this pathway in the mesolimbic pathway.
Specifically, systemic genotyping across the DRD2/ANKK1 region suggests evidence of
an association between SNPs in the region and severe alcohol dependence and
antisociality (Dick and Bierut, 2006).
Genes involved in the regulation of the serotonin system are also candidates for
involvement in the AD pathophysiology. Serotonin (5-HT) is involved in many aspects
of alcohol consumption, abuse, and dependence. The gene encoding the 5-HT transporter
(5-HTT) exhibits a functional polymorphism in which the shorter allele has lower
transcriptional efficiency. A meta-analysis of this variant demonstrated a significant
association between AD and the short allele (Fein et al, 2005).
Current research focuses on genes identified in association with alcohol
dependence in the context of several major neurobiological pathways including alcohol
metabolism and neurotransmitter systems.
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Figure 10. List of candidate genes involved in AD and alcohol related phenotypes. The
list was compiled from published reports of candidate genes in human studies and the list
of candidates on the ‘addictions’ array chip (Hodgkinson CA et al, 2008). Human
chromosome ideogram from Dept. of Pathology, Univ. of Washington
(www.pathology.washington.edu) (Kalsi G et al., 2008).

35

Figure 11. Top candidate genes. Pyramid generated by the tabulation of independent
converging lines of evidence, the CFG method. (Rodd ZA et al., 2007).
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CHAPTER 2: RESEARCH PROPOSAL
2.1

Rationale
Chronic alcoholism has been associated with global changes in brain morphology

and is a complex, multi-factorial disorder resulting from the interplay between genetic
and environmental factors. Chronic ingestion of alcohol adversely impacts brain systems
involved in cognition and alters sensitivity to the rewarding effects of alcohol. This
breakdown of the “reward cascade,” includes insensitivity to natural rewards, increased
sensitivity to alcohol and repeated cycles of abuse and eventually, an alcohol use disorder
(AUD). A well-known target of damage is the frontal cortex of the brain and the
circuitry of the mesolimbic pathway, linking the thalamus, the caudate putamen, the
nucleus accumbens, the amygdala, and the hippocampus—the seat of the modulation of
reward and punishment in addiction (see Figure 12). The cortical and sub-cortical limbic
aspects are connected and modulated by several white matter tracts, specifically the
cingulum bundle (gyrus and hippocampal aspects), the uncinate fasciculus, the inferior
fronto-occipital fasciculus, the inferior and superior longitudinal fasciculus, the forceps
minor and major, the anterior thalamic radiation and the corticospinal tract (see Figure
13). Furthermore, these combined cortical and sub-cortical regions overlap brain regions
involved in memory, emotion, and reinforcement, which are adversely affected by
damage to gray matter regions and/or by degradation of interconnecting white matter
tracts. This damage can be traced using non-invasive in vivo neuroimaging techniques
such as Magnetic Resonance Imaging (MRI) and Diffusion Tensor/ Diffusion Weighted
Imaging (DTI/DWI) which characterizes neuronal dysfunction. Previous researchers
have reported alcoholism related damage in several cortical and sub-cortical structures
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using MRI and previous DTI studies have shown several damaged white matter tracts in
alcoholic subjects seen by widespread low fractional anisotropy (FA) values (Brewer and
Perrett, 1971; Cala et al, 1985; Pfefferbaum et al, 2004; Pfefferbaum et al, 1992; Agartz
et al, 1999; Pfefferbaum et al, 2008).
AD is a complex disorder with multiple genetic backgrounds. The susceptibility
genes that are the focus of the present study, were chosen because they are known to
encode for underlying mechanisms that are linked to the pathophysiology of alcoholism.
These postulated candidate genes and genetic studies of AD examine the metabolism of
alcohol and the dopaminergic, GABAergic, glutamergic, opioid, serotonergic and
cholinergic neurotransmitter systems.

Genes typically have multiple functional

polymorphisms and affect neural networks globally, not just isolated brain regions and
only alcohol metabolism and neurotransmitter systems. For this reason, several SNPs in
genes involved in growth and myelination have been chosen to focus on morphological
changes in the cortical and subcortical regions of the brain involved in alcohol
dependency. The combination of neuroimaging data (which may represent candidate
endophenotypes or disease vulnerability markers of AD) with genetic information
appears to be a valuable way to study a particular subset of polymorphisms which may
have functional consequences. Recent studies demonstrate that specific polymorphisms in
genes associated with myelination and synaptic plasticity are associated with subtle
alterations in the white matter connectivity and structures of the cortical and sub-cortical
regions (Agartz et al., 1999). Furthermore, some of these polymorphisms correlate with
alterations in sub-cortical structures of the limbic pathway associated with cognitive
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dysfunctions and symptoms of alcoholism (Puls et al., 2008). These findings suggest that
these specific SNPs may influence the deleterious effects of alcohol on brain structure.
Studying a group of anatomic regions, which are components of structural and
functional circuits, is an important avenue in identifying a biomarker for a disease. Here
we will use fiber tracking to examine the variation in the effects of low and high alcohol
dependence on fiber quality of multiple major association, projection tracts and structures
involved in vulnerability to the effects of chronic alcohol use. It has been previously
reported that long-term alcohol consumption leads to degeneration of white matter and
grey matter structures in cortical and sub-cortical regions of the brain. Previous research
has shown a reduction of hippocampal volume in alcoholics (Kurth et al., 2004) and
changes in white matter (Harding et al., 1997). Quantitative morphometric studies show
brain volume shrinkage that relates to a reduction in the volume of the white matter in the
cerebral hemispheres rather than volume changes in the cerebral cortex. MRI studies
have reported that the greatest cortical and sub-adjacent white matter loss occurs in the
frontal lobes (Pfefferbaum et al., 1997). However, the characteristics of morphological
changes within most of the structures in the sub-cortical regions, including the limbic
loop, specifically, have not been reported and are poorly understood. In addition to
previously published data on the hippocampus and amygdala, morphological changes in
the caudate-putamen and the nucleus accumbens have yet to be quantified. As for white
matter tracts between and around these primary structures of the limbic pathway the
cingulum bundle (gyrus and hippocampal aspects), the uncinate fasiculus, the inferior
fronto-occipital fasciculus, the inferior and superior longitudinal fasciculi, the uncinate
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fasiculus, the forceps minor and major, the anterior thalamic radiation and the
corticospinal tract must also be quantified in alcohol dependent individuals.
Like brain regions, genes do not operate in isolation. In lieu of this, analysis of
connections among regions can be used to identify brain networks that are affected by
genetic variation. Regions of interest (ROIs) are identified based on a priori hypotheses
and brain alterations assessed by MRI or DTI.

Individuals are then genotyped for

candidate alleles yielding two or more different genotype groups to compare.

By

examining the strength of correlation between the morphological changes (from Specific
Aim 1) and the genetic profiles of the alcohol dependent individuals, we can indicate
what genotype influences certain phenotypes, predisposing certain tissue to early damage
or resiliency. The ultimate directive is to integrate genes and their products with brainbased intermediate/structural phenotypes of clinical disease, alcoholism, producing a
biomarker or susceptibility marker for disease progression.
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Figure 12. Brain regions involved in the extended reward system. Prefrontal and
cingulated regions connect to the nucleus accumbens (NA), the midbrain ventral
tegmental area (VTA), and reciprocally with other limbic system structures (amygdala
and hippocampus). The VTA projects to the NA, to the thalamus and hypothalamus and
to the prefrontal cortex (Makris N et al., 2008).

Figure 13. DTI target locations of 6 of the 11 bilateral fiber bundles identified on
coronal images of the population-average FA template and representative colorized fiber
bundles superimposed on a composite saggital image of six fiber bundles (Makris N et
al., 2008).
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2.2

Hypothesis And Specific Aims
The experiments in this proposal utilized MRI to determine whether alcohol

dependence is associated with structural brain changes and to determine whether specific
SNPs, previously linked to structural changes, are associated with the brain changes that
may result from chronic exposure alcohol. The hypotheses and specific aims are:
2.2.1

Hypotheses
We hypothesize that a level of alcohol dependence is associated with alterations

in gray matter volume and white matter coherence and that specific SNPs in genes
involved in growth & plasticity and myelination will be associated with the alterations in
gray matter volume and white matter coherence.
2.2.2

Specific Aim 1
Determined whether white matter connectivity and cortical and sub-cortical

grey matter volumes are different in individuals with high levels of alcohol
dependence versus those with low levels of dependence. Their scale score on the
Alcohol Dependence Scale behavioral test determined the low and high alcohol
dependent individuals. Low and high alcohol dependent subjects had been scanned in a
3-Tesla scanner to obtain whole brain MRI images. We used DTI fiber tractography
software to measure tract length and volume and analyzed using IDL software to
determine white matter tract integrity/coherence of low and high alcohol dependent
subjects. The obtained fractional anisotropy (FA) measurements should show greater
demyelination in the cingulum bundle (gyrus and hippocampal aspects), the uncinate
fasiculus, the inferior fronto-occipital fasciculus, the inferior and superior longitudinal
fasciculus, the uncinate fasiculus, the forceps minor and major, the anterior thalamic
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radiation and the corticospinal tract regions of high alcohol dependent subjects versus
low alcohol dependent subjects. We also determined changes in volume of cortical and
sub-cortical structures—the thalamus, the nucleus accumbens, the caudate-putamen, the
amygdala, and the hippocampus, in low versus high alcohol dependent subjects, using the
same MRI whole brain scans and FreeSurfer software for analysis.
2.2.3

Specific Aim 2

Tested whether single nucleotide polymorphisms (SNPs) in genes related to
myelination and growth are associated with differences in the structural measures
described in Specific Aim 1. For these association studies we used genes with SNPs
that have been previously known to show dysfunction in disease states such as
alcoholism, schizophrenia, and depression. These predisposed genes for white matter
tracts are SNPs in Myelin Associated Glycoprotein (MAG) functionally known to initiate
and maintain the myelin sheath and Oligodendrocyte Transcription Factor 2 (OLIG2), a
transcription factor of myelin-specific genes. The predisposed genes for cortical and subcortical structures are SNPs in Brain Derived Neurotrophic Factor (BDNF), Nuclear
Factor of Kappa Light Polypeptide Gene Enhancer in B-cells 1 (NFKB1) and
Neurotrophic Tyrosine Kinase, Receptor, Type 2 (NTRK2), all involved in
development/growth, immune response, and learning and memory. The genetic profiles
of low and high alcohol dependent subjects were obtained in reference to the specified
SNPs using BeadStudio. The percentages of frequent, heterozygous and rare alleles were
mapped with FA and MD values of white matter coherence and cortical and sub-cortical
grey matter volumes (obtained in Specific Aim 1). An association analysis, with the
integration of an alcohol dependent individuals’ genetic information with their white and
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grey matter damage, was performed to uncover an invariant and interactive relationship
between a SNP predisposing tissue to damage or an exacerbation or protection of this
tissue due to an endophenotype of alcohol dependence.
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CHAPTER 3: RESEARCH AND EXPERIMENTAL METHODS
3.1

Introduction
In general, the volume, FA, MD, AD and RD values were obtained for ten major,

well-documented, white matter tract bundles from low and high alcohol dependent
individuals whole brain DTI images (n=36). The ten major ROIs tracked were the right
and left of each of the following: the cingulum (gyrus and hippocampal aspect), the
inferior fronto-occipital fasciculus, the inferior and superior longitudinal fasciculus,
uncinate fasiculus, the forceps minor and major, the anterior thalamic radiation and the
corticospinal tract. In addition to this, the volumetric measurements of nine cortical and
subcortical structures—the cortex, thalamus, caudate, putamen, hippocampus, amygdala
and accumbens were also obtained from the MRI full brain scan.
Candidate genes were then selected that had been previously indicated to show
SNPs that are associated with a disease, such as schizophrenia, depression as well as
alcoholism. The saliva samples from the low and high alcohol dependent individuals
scanned provided the genetic profiles and SNP distribution. The genetic profiles were
correlated with gray matter structures and white matter tracts showing significant
differences to demonstrate an interaction of AD with a specific phenotype and genotype.
3.2

Demographics and Subject Selection
A total of 45 individuals will be included in the final cohort of 21-30 years of age

for gray matter alterations and 36 individuals for white matter alterations. Participants
were recruited through flyers, mass emails, and newspaper advertisements. Individuals
were screened on the phone for specific drinking criteria (see Table 1). Individuals who
met these criteria were scheduled for a subsequent screening session during which they
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provided a DNA sample.

The genotype profile was assayed using the procedures

described below (Section 3.5 Genotyping).

Because sample characteristics could

increase error variability, the criteria for inclusion per participant were tightly controlled.
Table 1. Required criteria for inclusion in current study.
TABLE Crit eria for Inclusio n in St udy
1. Age 21 -30yrs
2. Alco hol consumption a t least tw ice per week and a t least 3 drinks per
occasio n during 4 consecutive w eeks prio r to be ginning the stud y;
3. Breath alco hol level of 0.00 at scree ning
4. No history of treatm ent for alcohol depe ndence
5. No history of severe alcohol withdrawal
6. No history of injury to th e brain or brain rela ted medical p roblems;
7. Not currently taking an y psycho tropic medications
8. No evidence of rece nt illicit drug u se

In general, study participants were required to complete an Alcohol Use Disorders
Identification Test (AUDIT) from which ADS (Alcohol Dependence Scale) number was
assigned. The questionnaire discusses loss of behavior control, obsessive drinking style,
psychoperceptual and psychosocial withdrawal, setting up a total number for level of
dependence (see below for details: Individual Difference Measures). The population was
then ranked and set into quartiles with the first quartile defined as low alcohol
dependence, and the fourth quartile defined as high alcohol dependence. The 21-30 years
of age cohort was used for this study and due to a lack of preprocessing by FSL of the
MRI scans of several of the subjects, the cohort was split into gray matter and white
matter subgroups for ease of analysis (Table 2).
Depression, taken into account by the BDI-II that was administered to the
subjects, showed a significant correlation with ADS and was taken into account as a covariant in all analyses (Graph 1).
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Table 2. Demographics of ADS individuals between 21-30 years of age. Number of
men and women is indicated as well as the average age. Average maximum drinks are
within the past week. Quartiles were set based on an original date set of 192 individuals
for ADS and BDI-II.
Demographics and Clinical Characteristics of Individuals Grey Matter Cohort
Low ADS High ADS
men/women
18/8
17/2
Q1=Low ADS (< 7)
Age (years)*
24
26
Q4=High ADS (> 16)
Avg. Max Drinks
13
18
Smoker/Non-Smoker
7 19
9 10
Q1=Mild Depression (< 3)
ADS Score
5
18
Q4=Severe Depression (> 14)
BDI-II* Score
4
11
*Avg. Age = 25y
**Beck's Depression Inventory-II
Demographics and Clinical Characteristics of Individuals White Matter Cohort
Low ADS High ADS
men/women
15/6
13/2
Q1=Low ADS (< 7)
Age (years)*
23.9
25.9
Q4=High ADS (> 16)
Avg. Max Drinks
13.7
15.6
Smoker/Non-Smoker
5 16
6 9
Q1=Mild Depression (< 3)
ADS Score
5
17
Q4=Severe Depression (> 14)
BDI-II* Score
4
12
*Avg. Age = 24.9y
**Beck's Depression Inventory-II
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Graph 1. ADS scale score showed a significant correlation with BDI-II score. For this
reason BDI was accounted for in all analyses as a co-variant.

3.2.1

Pre-Procedure
Drinking alcohol within 24 hours of the experimental session was prohibited.

Each subject was tested using a breathalyzer to insure that no alcohol had been consumed
and only subjects with a breath alcohol concentration of zero were allowed to participate
in the scan session. After being tested for alcohol in the system (using a brethalyzer),
subjects completed a DSM IV interview for alcohol dependence and the measures related
to personality, drinking history, drinking problems, and family history of alcohol
problems prior to scanning (Individual Difference Measures, see below for explanations:
DQ, TLFB, TPQ, ADS, ADD and BDI-II). These tests were administered by Julie
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McCollough and Flora Soto-Endicott. After the individual difference measures were
completed (approximately 1.5 hours), the participant was prepared for the imaging part of
the experiment. Once subjects were comfortable with the procedures they were inserted
into the bore of the magnet for a high-resolution 3D spoiled gradient echo T1-weighted
image that is collected for image registration and normalization.
Individual Difference Measures.
The following questionnaires were given to subjects who meet the criteria for
inclusion in order to examine variables that may mediate or moderate the effects of
alcohol.
1. A Demographics Questionnaire was used to collect information on age, sex,
marital status, SES, occupation, income, education, and race/ethnicity.
2. A Time Line Follow Back (TLFB) interview (Sobell, 1980) was used to assess the
quantity and frequency of drinking within the past month.

The TLFB is a

calendar assisted structured interview that provides the subject with temporal cues
to increase the accuracy of recall. This interviewer-administered instrument has
demonstrated test-retest reliability and validity (Sobell & VanderSpek, 1979).
3. The Tridimensional Personality Inventory (TPQ) is a 100-item questionnaire with
good reliability and validity (e.g., Cloninger, 1987). The TPQ consists of three
main scales that include Harm Avoidance, Reward Dependence, and Novelty
Seeking.
4. The Alcohol Dependence Scale (ADS) was used to collect information on the
severity of alcohol symptomatology within the last year. The ADS has proven to
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be a valid and reliable measure of the severity of alcohol dependence (Skinner &
Allen, 1982).
5. Alcohol Dependence Diagnosis was derived from the alcohol portion of the
Structured Clinical Interview for DSM-IV, Nonpatient Version (SCID-IV).
6. The Beck’s Depression Index-II is a 21-item self-report instrument intended to
assess the existence and severity of symptoms of depression as listed in the
American Psychiatric Association's Diagnostic and Statistical Manual of Mental
Disorders Fourth Edition (DSM-IV; 1994). BDI has been used for 35 years to
identify and assess depressive symptoms, and has been reported to be highly
reliable regardless of the population. It has a high coefficient alpha, (.80) its
construct validity has been established, and it is able to differentiate depressed
from non-depressed patients (Beck et al, 1974).
3.3

Neuroimaging: Magnetic Resonance Imaging (MRI) and Diffusion Tensor

Imaging (DTI)
The project utilized the facilities of the University of Colorado Brain Imaging and
Drug Abuse Center. A GE 3T whole body MRI scanner provides an increased signal-tonoise ratio. With the increased signal-to-noise reduced pixel size and slice thickness
were obtained. The enhanced gradient coils in the 3T scanner allow much faster
acquisition time as well. Data was collected with a 64x64 matrix over a 200mm x 200mm
FOV (in-plane resolution of 3.125mm x 3.125mm) with TE = 30 ms and TR = 2500 ms.
Each data set consisted of 40 oblique slices, 3 mm thick with a 1 mm gap, angled parallel
to the planum sphenoidale. The inversion-recovery SPGR sequence was used to acquire
an axial 3-D anatomical image volume with optimal T1 contrast (TI=500 ms, FA=7
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degrees, slice thickness=1.5mm, 256x256 matrix, 200mm x 200mm FOV, bandwidth
=15.6kHz, 124 slices). The imaging time for the 3-D anatomical volume is about 10
minutes. The EPI images, the inversion-recovery SPGR sequence will be used to acquire
an axial 3-D anatomical image volume with optimal T1 contrast (TI=500 ms, FA=7
degrees, slice thickness=1.5mm, 256x256 matrix, 200mm x 200mm FOV, bandwidth
=15.6kHz, 124 slices). At the beginning of the experiment, a T1-weighted spin echo data
set (40 axial slices of part head, matrix = 512 x 512) was acquired using the same slice
angles, thickness, and gap as the EPI images. The purpose of the T1 spin echo data set is
to optimize co-registration of functional images to volumetric T1 data set.
DTI data were acquired using a single-shot echo-planar imaging with sensitivity
encoding (SENSE, parallel-imaging factor, 2.5) (Prussmann et al, 1999). The imaging
matrix was 96x96 with a field view of 240x240 mm (nominal resolution, 2.5mm), zero
filled to 256x256 pixels. Transverse sections of 2.5 mm thickness were acquired parallel
to the anterior commissure/posterior commissure line. Diffusion weighting was encoded
along 30 independent orientations (Jones et al, 1999) using b-value of 700mm2/s. The
scanning time per dataset was approximately 6 min including 2 min image reconstruction
delay (see Figure 14 for general representation).
In general, DTI datasets were processed using the analysis software DTIStudio
(developed and distributed by Johns Hopkins University, http://lbam.med.jhmi.edu).
Images were first realigned using the AIR program (Woods et al, 1998), in order to
remove any potential small bulk motions that occurred during the scans. The six elements
of the diffusion tensor were calculated for each pixel using multivariate linear fitting.
After tensor diagonalization, three eigenvalues and eigen vetors were obtained and
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fractional anisotropy were calculated (Wakana et al, 2007). The eigenvector associated
with the largest eigenvalue was used as an indicator for fiber orientation. DTIStudio, in
the color maps, colors were assigned to specific directions of fibers: red, green and blue
were right-left, anterior-posterior, and superior-inferior, respectively.

Figure 14. Pulse sequence diagram for a diffusion-weighted acquisition shows that 2
diffusion sensitizing gradients (dark gray) are added to a spin-echo sequence, 1 before
and 1 after the 180 degree refocusing pulse. The diffusion weighting factor depends on
the amplitude of the diffusion gradient (G), the duration of each diffusion gradient (δ),
and the interval between the onset of the diffusion gradient before the refocusing pulse
and that following the refocusing pulse (∆). RF indicates the radiofrequency pulses and
the readout of the water molecules, Gz, gradient pulses. (Mukherjee P et al., 2008).

3.4

Quantification

3.4.1

FreeSurfer and Gray Matter Volumes
FreeSurfer is an MRI brain imaging software package developed by the Athinoula

A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital with
support from CorTechs Labs, Inc, La Jolla, CA. A functional tool in brain mapping, it
facilitates the visualization of the functional regions of the highly-folded cerebral cortex.
It contains both volume based and surface based analysis, which primarily use the white
matter surface (Dale, A. M., B. Fischl, et al, 1999). FreeSurfer includes tools for the
reconstruction of topologically and geometrically accurate models of both the gray/white
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and pial surfaces, for measuring cortical thickness, surface area and folding, and for
computing inter-subject registration based on the pattern of cortical folds. In addition to
this, the software contains an automated labeling of 35 non-cortical regions.
With respect to preprocessing of the MRI data, the images in each
participant’s time series were motion corrected using MCFLIRT module of FSL
(FMRIB’s Software Library) package (created by Image Analysis Group in FMRIB,
Oxford University). Images in the data series were (1) spatially smoothed with a 3D
Gaussian kernel (FWHM = 6 x 6 x 6 mm3), (2) intensity normalized for all volumes by
the same factor and (3) temporally smoothed using a high-pass filter. The FEAT
(FMRIB’s Easy Analysis Tool) module of FSL package will be used for these steps and
later statistical analysis. After statistical analysis for each subject’s time series, statistical
maps were warped into the common MNI stereotaxic space before random effect group
analysis is performed. To do so, (1) An average EPI volume will be registered to a high
resolution partial head volume taken at the same orientation and with an equal number of
slices. (2) This same partial head volume will be registered to a high-resolution full head
volume. (3) Last, this full head volume will be registered to an average brain in MNI
space. Transformation matrices generated were used to register the final statistical results
into the average MNI space. Coordinates were reported in both MNI and Taliarach space
(T-space). This processing used the FLIRT (FMRIB’s Linear Image Registration Tool)
module of the FSL package.
The FreeSurfer processing stream is controlled by a shell script called recon-all.
The script calls component programs that organize raw MRI images into formats easily
usable for morphometric and functional MRI statistical analysis with the FS-FAST
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package. Freesurfer uses a morphed spherical method to average across subjects for a
GLM group analysis with the QDEC tool. FreeSurfer automatically segments the volume
and parcellates the surface into standardized regions of interest (ROIs) that the Center for
Morphometric Analysis has developed.
The volume-based stream is designed to preprocess MRI volumes and label
subcortical tissue classes. The stream consists of five stages (fully described in Fischl, et
al, 2002, 2004b). The first stage is an affine registration with Talairach space specifically
designed to be insensitive to pathology and to maximize the accuracy of the final
segmentation.

This is followed by an initial volumetric labeling. The variation in

intensity due to the B1 bias field is corrected. Finally, a high dimensional nonlinear
volumetric alignment to the Talairach atlas was performed. After the preprocessing, the
volume is labeled (see below). The volume-based stream has evolved somewhat
independently from the surface-based stream. The volume-based stream only depends
upon the skull stripping to create a mask of the brain in which the labeling is performed.
The final segmentation is based on both a subject-independent probabilistic atlas
and subject-specific measured values. The atlas is built from a training set, i.e., a set of
subjects whose brains (surfaces or volumes) have been labeled by hand. These labels are
then mapped into a common space (Talairach space for volumes and spherical space for
surfaces) to achieve point-to-point correspondence for all subjects. Note that a "point" is
a voxel in the volume or a vertex on the surface. At each point in space, there exists the
label that was assigned to each subject and the measured value (or values) for each
subject. Three types of probabilities are then computed at each point. First, the
probability that the point belongs to each of the label classes is computed. The second
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type of probability is computed from the spatial configuration of labels that exist in the
training set, which is termed the neighborhood function. The neighborhood function is
the probability that a given point belongs to a label given the classification of its
neighboring points. The neighborhood function is important because it helps to prevent
islands of one structure in another at the structure edges. Third, the probability
distribution function (PDF) of the measured value is estimated separately for each label at
each point. For volume-based labeling, the measured value is the intensity at that voxel.
The classification of each point in space to a given label for a given data set is
achieved by finding the segmentation that maximizes the probability of input given the
prior probabilities from the training set. First, the probability of a class at each point is
computed as the probability that the given class appeared at that location in the training
set times the likelihood of getting the subject-specific measured value from that class.
The latter is computed from the PDF for that label as estimated from the training set. The
probability of each class at each point is computed. An initial segmentation is generated
by assigning each point to the class for which the probability is greatest. Given this
segmentation, the neighborhood function is used to re-compute the class probabilities.
The data set is re-segmented based on this new set of class probabilities. This is repeated
until the segmentation does not change. This procedure allows the atlas to be customized
for each data set by using the information specific to that data set. Once complete, not
only is there a label for each point in space, but there is also the probability of seeing the
measured value at each voxel. The product of this probability over all points in space
yields the probability of the input. This procedure has been shown to be statistically
indistinguishable from manual raters (Fischl, et al, 2002) and relatively insensitive to
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changes in acquisition parameters (Fischl, et al, 2004a). The results are shown in Figure
15, the volumetric labeling shows several subcortical structures (putamen, hippocampus,
ventricles, etc). In FSL all white matter is considered a single label, and so another
program is used for tracking white matter from the DTI image obtained.
For this project, the automated pipeline and script obtained values for cortical and
subcortical volumes for cortex, thalamus, caudate, putamen, hippocampus, amygdala and
accumbens.
(A)

(B)

Figure 15. Volume based labeling. (A) Volume-based labeling. Note that cortical gray
matter and white matter are represented by single classes. Also note that there are
separate labels for the structures in each hemisphere. (B) Surface-based labeling.
(FreeSurferAnalysisPipelineOverview, http://surfer.nmr.mgh.harvard.edu/fswiki/).

3.4.2

DTIStudio and White Matter Tractography
DTIStudio is a program developed for diffusion tensor image (DTI) computation

and fiber tracking. The software reads data formats from a variety of MR scanners.
Tensor calculation is performed by solving an over-determined linear equation system
using least square fitting. Various types of map data, such as tensor elements,
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eigenvalues, eigenvectors, diffusion anisotropy, diffusion constants, and color-coded
orientations can be calculated. The results are visualized in orthogonal views and in a
three-dimensional mode. Three-dimensional tract reconstruction is based on the Fiber
Assignment by Continuous Tracking (FACT) algorithm and a brute-force reconstruction
approach (Mori et al, 1999; Xue et al, 1999). To improve the time and memory
efficiency, a rapid algorithm to perform the FACT is adopted (for a complete overview
from voxel to tract please see Figure 16). An index matrix for the fiber data is introduced
to facilitate various types of fiber bundles selection based on approaches employing
multiple regions of interest (ROIs). The program is developed using C++ and OpenGL on
a Windows platform (Jiang et al, 2006).
In general, for 3D tract reconstruction, fiber assignment by FACT method was
used with FA threshold 0.2 and an inner product threshold of 0.75, which prohibited
angles larger than 60 degrees during tracking. A multi ROI approach was used to
reconstruct tracts of interest. Tracking was performed from all pixels inside the skull
(brute force approach) (Conturo et al, 1999) and results penetrating manually defined
ROIs. When multiple ROIs were used for a tract of interest, three types of operations
were employed, “AND”, “CUT”, and “NOT” (see Figure 17), the choice of which
depends on the characteristic trajectory of the WMT (Wakana et al, 2007).
For this project, the chosen tracts in question that were tracked using DTIStudio
were the cingulum (gyrus and hippocampal aspect), the inferior fronto-occipital
fasciculus, the inferior and superior longitudinal fasciculus, uncinate fasiculus, the
forceps minor and major, the anterior thalamic radiation and the corticospinal tract (see
Appendix I for tracking reconstruction).
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Figure 16. Fiber tracking: connecting voxels. Several approaches together connect
voxels after white matter fibers have been identified and their orientation determined. (a)
With the FACT algorithm, tracking is performed on a voxel-by-voxel basis. The overall
track is determined from a seed point, following successive orientations associated with
adjacent voxels (Mori S et al., 1999) (b) Regularization methods allow local patterns
fiber stiffness to be taken into account. Voxels with uncertain orientation (blue) can then
be included or excluded from tracts, depending on the allowed degree of curvature of the
tracks (Poupon C et al., 2000).
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Figure 17. A schematic diagram of 3 types of ROI operations; AND, NOT , and CUT.
After the first ROI is drawn, all tracts that penetrate that ROI are retrieved (A). When the
second ROI is applied as an “AND” operation, the fibers that penetrate both ROIs are
retained (B). Fibers leading to other pre-determined tracts may be deleted from the ROI
using the “NOT” operation (C) leaving the ROI in question (D). For example, for the
corticospinal tract we see the first ROI above the decussation (E) “AND” the second ROI
below the pyramidal cells of the motor cortex (E) leaving the ROI and the fibers to be
tracked (F). (Wakana S et al, 2007).

3.5

Genotyping

3.5.1 Whole-genome Genotyping & CNV analysis on the Illumina® Infinium®
Assay Platform using the Human1M-duo V3 BeadChip
DNA Collection, Extraction, and Storage:
Participants were instructed to generate and deliver 5 ml of saliva in to a sterile 50
ml conical centrifuge tube. The saliva sample was then placed in the refrigerator and lysis
buffer was added within 24 hours. Tris-HCl, pH 8; EDTA, pH 8; SDS and NaCl were
added at 100 mM, 20 mM, 0.5% and 125 mM final concentrations; respectively. The
tubes are refrigerated until the DNA is extracted, usually within 48 hours. Proteinase K
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(0.2 mg/ml) is added and the tubes are incubated at 65°C for 60 minutes. An equal
volume of isopropyl alcohol is then added to each tube, the contents are mixed, and the
DNA is collected by centrifugation at 3,500 x g for 10 minutes. The DNA pellet is rinsed
once with one ml of 50% isopropyl alcohol and allowed to air dry. For RNase treatment,
20 ug/ml RNAse A and 50 U/ml RNase T1 were added and incubated at 37oC for 30
minutes. To precipitate the DNA, two volumes of 95% ethanol was added and mixed by
gentle inversion then collected by centrifugation at 3,500 xg for 15 minutes. The samples
were allowed to air dry followed by re-suspension in 1 ml of 10 mM Tris-HCl, 10 mM
EDTA buffer, pH 8.0, and placed in a 1.8 ml cryovial. The concentration of DNA is
calculated from the absorbance at 260 nm analysis and then adjusted to a concentration of
10 ng/μL.
Protocol:
The DNA is then purified and quantified in preparation for whole genome
amplification, followed by fragmentation and ethanol precipitation. The DNA is then resuspended in hybridization buffer and applied to the bead chip array for an overnight
incubation. The amplified and fragmented DNA samples anneal to locus-specific 50-mers
(covalently linked to one of over 1,000,000 beadtypes) during the hybridization step.
Following hybridization, the arrays are washed to eliminate unhybridized and nonspecifically hybridized DNA. One bead type corresponds to each allele per SNP locus.
The samples then undergo single base extension and staining followed by more washing.
The arrays are allowed to dry and then scanned using the Illumina iScan system and in
turn analyzed using Illumina’s software for automated genotype calling performed by
Marilee Morgan.
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Data Analysis:
Analysis of the scanned results was achieved using Illumina’s BeadStudio
software in conjunction with the BeadStudio genotyping module. BeadStudio Software is
a modular analysis tool for genotyping, gene expression, and methylation applications.
The data is then filtered in BeadStudio for call rate, call and minor allele frequency to
remove bad samples and bad SNP’s. BeadStudio comes equipped with several plug-ins to
generate compatible files for further analysis using third party and/or custom software
packages.
3.5.2

Candidate Gene Identification

Haploview: Statistical analyses for linkage disequilibrium, single SNP association,
and haplotype-based association
Linkage disequilibrium was estimated based on the formula: D = Pab-Pa•Pb. D is
LD (normalized by the maximum value of possible D); Pab is the haplotype expectation
frequency at loci A and B. The terms Pa and Pb are allele frequencies at two loci. LD was
estimated using the Haploview program (Barett et al., 2005). If D′ values are ≥ 0.98,
there is little evidence for historic recombination. Thus, the two markers are considered
to be in “strong LD” (Gabriel et al., 2002). An LD block was defined according to
Gabriel’s definition that less than 5% of comparisons among informative SNP pairs show
strong evidence of historic recombination.
Gray Matter Candidate Genes
Growing evidence from neuroimaging, histological, and gene expression studies
suggests that volumnar deterioration in limbic structures may contribute to the
development of alcoholism. Genetic studies have identified polymorphisms in several
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genes important in growth, BDNF and its binding receptor NTRK2, also known as
TRKB. Linkage findings in the addictions, particularly cigarette smoking with or without
alcohol dependence, have been reported for loci on chromosomes 9 and 11,
corresponding to the locations of TRKB and BDNF, respectively. In addition to this, the
Collaborative Study on the Genetics of Alcoholism (COGA) performed whole-genome
linkage analysis in a sample of families that include alcoholic first-degree relatives
(Nelson et al, 1995). A broad region on chromosome 4q was found linked to the
phenotype of alcohol dependence in these families (Reich, 1996).

Located on this

chromosome at 4q24 is NFKB1 and appears to affect the risk of alcoholism, particularly
contributing to an earlier onset of the disease (Rodd ZA et al., 2008). We then correlated
these SNPs with DTI data and other neuroimaging information in high and low
dependence alcoholic subjects.
BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF)
GENE: BDNF LOCATION: CHRM. 11
Candidate gene studies and linkage-based genome scans have identified multiple
chromosomal regions as sources of susceptibility to AD, showing some convergent
findings. Previous research concurrent with the present study, has shown that cigarette
smoking with or without AD, has been linked to broad regions of chromosomes 9 and 11.
Among candidate addiction susceptibility genes defined by these linkage signals are
those that encode the neurotrophin, brain derived neurotrophic factor (BDNF, chrm. 11),
and its cognate receptor, neurotrophic tyrosine kinase receptor B (TrkB, NTRK2, chrm.
9). Several polymorphisms in the gene for brain-derived neurotrophic factor (BDNF)
might play a role in the development of or vulnerability to alcoholism and/or clinical
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characteristics of alcoholic individuals. The gene maps to chromosome 11p13-15 and a
quantitative trait loci study has indicated that there is a gene localized to 11p13 that
increases the risk for severe alcohol withdrawal (Buck et al., 1997). Furthermore, a
linkage study to alcohol dependence suggested that the BDNF locus (Uhl et al, 2001) and
chromosome 11p15.5 were included in loci that a pooled-sample microarray showed an
association with drug abuse. More than 40 SNPs have been described in the BDNF gene
(Sklar et al, 2002) and among these is a SNP frequent in humans producing a
nonconservative amino acid substitution of a valine at codon 66 for a methionine
(Val66Met, dbSNP number rs6265), see Figure 18.
The distribution of the Met substitution is approximately 30%-50% of people
worldwide are heterozygous (Val/Met) or homozygous (Met/Met) for the methionine
substitution (Shimizu, Hashimoto & Iyo, 2004). Carriers of the Met allele make up about
30% of the U.S. population (Shimizu, et al, 2004), with the most commonly affected
individuals of Indo-European descent and of this only 4% in the U.S. are carriers of the
homozygous Met allele (Met/Met). An association study of BDNF gene polymorphism
and alcoholism has also demonstrated that the Val66Met polymorphism may play some
role in the course of the disease of alcoholism, rather than the development of
vulnerability to alcoholism (Matsushita et al, 2004). In this study the frequencies of
Met/Met genotype and the Met allele of the Val66Met polymorphism were significantly
higher in alcoholic subjects who had a history of alcoholism with deliriem tremens and
the Met allele advanced the onset of the disease (Matsushita et al, 2004).
The variant sequence is located in the 5’ pro-BDNF region, which encodes for the
precursor peptide (pro-BDNF) that is proteolitically cleaved to form the mature protein
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(Seidah et al., 1996). Although this polymorphism doesn’t affect the protein function of
mature BDNF, the Met allele has been shown to alter intracellular trafficking and
packaging of pro-BDNF, and thus the secretion of the mature peptide.

This was

demonstrated by Egan et al in 2003 in which rat hippocampal neurons transfected with
the Met allele exhibited abnormal intracellular trafficking and altered BDNF secretion
versus those cells transfected with the Val allele. Specifically, depolarization dependent
secretion of BDNF was significantly impaired when Met-BDNF failed to localize to
secretory granules or synapses (Egan et al, 2003). This study also employs in vivo
approaches - cognitive testing, and fMRI, to demonstrate that BDNF plays a role in
healthy human verbal episodic memory. Egan M.F., et al demonstrates the feasibility of
studying, in vivo, the effects of specific genes on hippocampal biology and memory and
implicates a specific genetic polymorphism as a factor of altered human hippocampal
function, which is likely to have an impact on susceptibility to illnesses. Hariri, A.R., et
al showed the contribution of the Val66Met allele to memory-related hippocampal
activity in healthy volunteers using blood oxygenation level dependent fMRI (BOLD
fMRI) during declarative hippocampal formation dependent memory tasks.

Results

indicated that Met carriers exhibited decreased hippocampal engagement in comparison
with Val homozygotes during both encoding and retrieval processes. This interaction
between the Val66Met and the hippocampal response accounted for 25% of the total
variation in the recognition memory performance (Hariri A.R., 2003).

These data

implicate a genetic mechanism for variation in normal human declarative memory.
Evidence supporting a role for BDNF signaling in mechanisms of alcohol
dependence has been well documented in humans as well as animal models. For example,
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Joe et al., demonstrated that the mean plasma BDNF level was significantly lower in
alcohol dependent patients than in normal controls. In animal studies, McGough et al,
has shown that in BDNF-deficient mice, decreased levels of BDNF lead to increased
ethanol sensitization and increased voluntary ethanol consumption after a two week
withdrawal compared to wild-type animals. In addition, this group showed that when
wild-type C57BL/6 mice were allowed to self-administer ethanol, having unlimited
access to both water and a 10% ethanol solution for four weeks, BDNF mRNA levels
were significantly increased in dorsal striatum, a brain region associated with motor
control. These results suggest that BDNF signaling is part of regulatory pathway that may
offset the development of dependence by limiting alcohol intake. This concept was
supported by a previous report where rats received an infusion of BDNF into the ventral
tegmental area (VTA), preventing drug-induced adaptations in a brain region known to
be involved in drug reinforcing behavior (Berhow et al, 1996).
Alcoholics frequently suffer from comorbid psychiatric disorders as well, making
elucidation of the underlying motivation to drink difficult. Anxiety, depression, PTSD,
bipolar disorder and schizophrenia all predispose patients to alcohol abuse (Goldstein, et
al, 2006).

Studies have linked the Val66Met allele with altered neuropsychiatric

disorders such as schizophrenia (Varnas et al, 2008), depression (Sen et al, 2003), and
bipolar disorder (Neves-Pereira et al, 2002; Sklar et al, 2002). Studies in schizophrenic
subjects have demonstrated that Met carriers perform worse in working and episodic
memory tests than Val carriers along with reduced grey matter (GM) volumes within
brain regions participating in verbal memory and visuospatial abilities (Ho, B. et al,
2006). In the Ho, et al study, carriers of the Met allele, regardless of whether healthy
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volunteers or schizophrenic patients, had smaller occipital and temporal lobe volumes
versus Val homozygotes.
A loss of BDNF-mediated signaling is also thought to play a role in major
depression (Duman et al, 1997). Neuroimaging data consistent with this demonstrates
reduced hippocampal volumes, among other regions, associated with depressed patients
compared with controls (Manji et al, 2003). Trait depression, has been found to moderate
the effects of the BDNF genotypes on hippocampal volumes with Met carriers with high
depression showing a reduction in GM volume of the mean hippocampus versus Val
homozygotes (Joffe et al, 2008). Studies using MRI have shown that Val/Met healthy
individuals have smaller hippocampal volumes relative controls homozygous for the Val
allele (Pezawas et al, 2004; Szeszko et al, 2005). Differences in cortical and hippocampal
morphology are one of the most reliable effects observed in carriers of the Met allele.
Thus, this polymorphism could be very informative to interpret the neuroimaging data of
the structures involved in addiction obtained on high and low alcohol dependence
subjects.
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(A)

(B)

Figure 18. View of BDNF gene and SNP. (A) NCBI EntrezNucleotide View of BDNF
gene and mRNA transcripts. Markers indcate location of SNP: Purple: rs6265
(Val66Met). The variant sequence is located in the 5’ pro-BDNF region, encoding the
precursor peptide (pro-BDNF) proteolitically cleaved to form the mature protein (Seidah
et al, 1996). (B) Haploview generated LD map of the BDNF region in HapMap CEU
population. Regions of high LD (D=1 and LOD>2) are shown in bright red. Markers
with lower LD are shown in red (with D value indicated as a percentage) through pink
(decreasing color intensity indicates decreasing D value). Regions with high D values
but low informativeness (LOD>2) are shown in light blue. Regions of low LD and low
LOD scores are shown in white.
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NEUROTROPHIC TYROSINE KINASE RECEPTOR B (TRKB)
GENE: NTRK2 LOCATION: CHRM. 9
As stated previously, candidate gene studies have identified multiple
chromosomal regions as sources of susceptibility to AD and previous research has shown
that cigarette smoking, with or without AD, has been linked to broad regions of
chromosomes 9 and 11. Among candidate addiction susceptibility genes, brain derived
neurotrophic factor (BDNF, chrm. 11), and its cognate receptor, neurotrophic tyrosine
kinase receptor B (TrkB, NTRK2, chrm. 9) have been implicated.
Neurotrophins, a family of developmentally regulated proteins, are critical for
differentiation and survival of post-mitotic neurons and in the process of synaptic
plasticity. The Trk family of receptors mediate the biological activity of neurotrophins by
intrinsic protein-tyrosine kinase activity (Greene et al, 1995), but with different binding
affinities for neurotrophins. The extracellular domain of the receptor contains two
cysteine rich regions separated by a leucine rich domain. Between those domains and the
plasma membrane are two IG like regions that are followed by the transmembrane
domain. Intracellularly, the receptor contains the Shc-binding site, a tyrosine kinase
domain and a tail region containing a PLC

binding site (Stoilov et al, 2002).

Specifically, TrkB receptor activation is mediated by high-affinity binding by BDNF that
results in receptor dimerization and trans-autophosphorylation of tyrosine residues in the
carboxyl-terminal intracellular domain that is required for activation of signaling
cascades. This activation also includes transcriptional activation of the BDNF gene
(BDNF) (Saarelainen, et al, 2001).
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At least three protein isoforms of TrkB are produced by alternative splicing of
NTRK2 pre-mRNAs. These isoforms are the full-length tyrosine kinase receptor
(TrkB.FL), an isoform lacking the tyrosine kinase domain (TrkB.T1), and an isoform
lacking the tyrosine kinase domain but containing a Shc binding site (TrkB.T2.Shc)
(Stoilov et al, 2002, see Figure 19). All three isoforms are expressed in brain, TrkB.T1
being the major isoform expressed in the adult brain in mostly glia and the
somatodendritic and axonal compartments of hippocampal and motor neurons (Haapasalo
et al., 2001) whereas TrkB.T2.Shc is neuron specific (Stoilov et al., 2002). Postulated
roles for these truncated isoforms include facilitation or inhibition of neuronal signaling,
ligand clearance or sequestration, and cell-cell adhesive effects, axonal outgrowth and
synaptic plasticity (Klein et al., 1990). The T1 and T2.Shc isoforms have dominant
inhibitory effects blocking BDNF signaling by sequestering full-length trkB receptors
within non-functional heterodimers preventing autophosphorylation (Eide et al., 1996).
The functions of the truncated TrkB isoforms are not known (Hartmann et al., 2004).
However, there is accumulating evidence that truncated TrkB isoforms have a
paradoxical role,--dominant-negative inhibitory activity on full-length TrkB receptors
versus mediating signal transduction independent of full-length TrkB receptors
(Haapasalo et al., 2001; Hartmann et al., 2004).
The

essential

functional

role

of

BDNF-TrkB-mediated

signaling

was

demonstrated in a model of neurodegeneration, where survival of hippocampal neurons in
culture derived from trisomy 16 mice, which produce the truncated kinase deficient
isoform, Trk-T1, that would have been destined to die were restored by introduction of
exogenous full-length TrkB (Dorsey et al., 2002).
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A role for TrkB linked to AD in humans has been reported once before which
found evidence for allele, genotype, and haplotype-based association of NTRK2 with AD,
antisocial personality disorder type, in a Finnish population providing evidence for a new
role of TrkB in addictive disorders (Xu et al., 2007).

Xu et al, showed a strong

significant allelic association between three markers and AD, SNPs (4, 5, and 30) were
represented more frequently in the AD group than in the controls, suggesting that these
SNPs were associated with AD in the Finnish population.
Xu et al used publicly available genotyping data from HapMap Public Release
#20 to compare patterns of LD between the CEU panel (90 individuals [30 trios] from
Utah), and the Finnish sample from their study. A total of 511 SNPs from NTRK2 were
genotyped by the HapMap project. Of these, 96 SNPs were selected from HapMap and
pairwise measures of LD determined for the NTRK2 region. Linkage disequilibrium of
the NTRK2 gene showed five LD blocks (Figure 19) and although only 43 SNPs were
used in this study, this suggested that the 43 SNPs selected were sufficient to represent
the “true” LD structure in this region. Block 3, which contained SNP 30, contained six
SNPs (SNP26 to SNP33), which covered exons 17 to 19. Ten SNP pairs were in
complete LD, producing D′ values > 0.99. In the present study, Illumina 1M Duo
contained SNP 27 (rs1822420), 30 (rs10780691) and 33 (rs4304401), being in complete
LD, all in complete LD (Xu et al, 2007).
A haplotype based association with AD produced four, seven-locus, haplotypes in
block 3, which accounted for 94% of chromosomes in the controls and 95% of
chromosomes in the alcoholic group. Within block 3, haplotype 3A contained the major
allele of SNP 30 and was at slightly higher frequency in the control group (0.503) than in
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AD subjects (0.424) (r2 = 5.858, P = 0.015, corrected P = 0.062), while haplotype 3B,
which included the minor allele of SNP 30, was more abundant in the AD group than the
control group, supporting the single allele association with SNP 30 that Xu, et al
suggested previously.
Xu et al.’s study provides supportive evidence for an association between
variation at NTRK2 and AD. Evidence of association between NTRK2 gene and AD used
both single locus and haplotype-based approaches. It is the long term remodeling of
neuronal circuitry that is thought to underlie development of addictive behaviors,
including AD (Nestler et al., 2005).
BDNF is well known to be essential for neuronal survival, protection, and
activity-dependent synaptic remodeling. BDNF signaling, via TrkB, may alter the
expression of target genes related to limiting alcohol of AD (McGough et al, 2004).
Global levels and region specific levels of trkB (rat TrkB) mRNA following chronic
alcohol exposure were determined and levels of trkB mRNA levels were increased in the
hippocampus of rats exposed to chronic ethanol, as determined by an RNase protection
assay (Tapia-Arancibia et al., 2001). Future studies are required to refine treatment
conditions and expression assays. With these issues in mind, Tapia-Arancibia et al.
observed an increase in trkB mRNA levels in the hypothalamus from chronic alcohol
exposed rats, a brain region known to be associated with satiety (Tapia-Arancibia et al,
2001). Increased TrkB expression or TrkB-mediated signaling may serve as a negative
regulatory pathway that acts to regulate ethanol intake. This concept is supported by
recent findings showing that NTRK2 was associated with increased risk to eating
disorders and personality traits related to anxiety (Ribases et al., 2005). Variation in
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NTRK2 affecting expression of full-length or truncated isoforms or their stability could
significantly affect this negative regulatory pathway. Thus, during chronic alcohol
exposure, individuals with decreased TrkB-mediated signaling may be at greater risk of
AD.
(A)

(B)

(C)

Figure 19. View of NTRK2 gene and SNPs. (A) Schematic of TrB.FL, TrkB.T1 and
TrB.T2.Shc (Baxter et al., 1997). (B) Haploview generated LD map of the NTRK2
region in HapMap CEU population. Regions of high LD (D=1 and LOD>2) are shown in
bright red. Markers with lower LD are shown in red (with D value indicated as a
percentage) through pink (decreasing color intensity indicates decreasing D value).
Regions with high D values but low informativeness (LOD>2) are shown in light blue.
Regions of low LD and low LOD scores are shown in white. (C) NCBI EntrezNucleotide
View of NTRK2 gene and mRNA transcripts. Markers indcate location of SNP:
Purple:rs1822420 (SNP27), Red:rs10780691 (SNP30), Slate:rs4304401 (SNP33). Full
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length TrkB receptor contains all three SNPs. Truncated form TrkB.T1 and TrkB.T2
contain only SNP 27 and SNP30, which falls in the 3’UTR.
NUCLEAR FACTOR-KAPPAB (NFκB)
GENE: NFKB1 LOCATION: CHRM. 4
NFKB1 extends 116kb along chromosome 4q24 and encodes a 105kDa Rel
Family protein. In its full-length form, it is an inhibitor of transcription, which is cleaved
to 50kDa DNA-binding subunit of NFκB, a ubiquitous transcriptional activator in
mammalian cells (Meffert et al., 2003, 2005). NFκB has since been found in the brain
and is expressed in neurons, glia and Schwann cells of the central and peripheral nervous
systems (Bakalkin et al., 1993; Kaltschmidt et al., 1994; and Meberg et al., 1996). The
NFKB1 gene is auto-regulated by NFκB and also regulates BDNF (Marini et al, 2004).
Marini et al identified an NFκB binding site within promoter III of the BDNF gene that is
regulated by NMDA receptors and contributes to NMDA mediated neuroprotection.
NFκB is important in NMDA-mediated neuroprotection, possibly by increasing
the expression of BDNF (Lipsky et al., 2001); NFκB expression may in turn be activated
by BDNF in an autocrine loop (Lipsky et al., 2001; Jiang et al., 2005). Ethanol attenuates
the NMDA-mediated increase in BDNF (Bhave et al., 1999). Recently, it was found that
in rats treated for 4 days with high levels of ethanol (to model binge drinking), NFκB
binding to DNA in rat brains increased, and substantial brain damage occurred (Zou et
al., 2006).
A broad region on chromosome 4q was found linked to the phenotype of alcohol
dependence in at least three alcoholic first degree relatives from the Collaborative Study
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on the Genetics of Alcoholism (COGA) (Williams et al., 1999). In 2007, Edenberg et al,
tested the association of NFKB1 with alcoholism. Nineteen SNPs in and near NFKB1
were analyzed in 219 multiplex alcoholic families of European descent. Family based
association analyses detected significant evidence of association with eight SNPs and
marginal evidence for five more with an association driven by the affected individuals
with earlier onset alcoholism (55% of the sample population with onset >21 years).
Further analysis of the age of onset has also provided evidence for the association of 12
more SNPs in this gene (Edenberg et al., 2008). From the Edenberg et al study 3 of the 12
SNPs showing an association with earlier onset of alcohol dependence (rs980455,
rs230530, rs1609798) were chosen for this particular study due to their appearance as
markers on the Illumina Array (see Figure 20). Although numerous SNPs have been
identified the functional impact of these SNPs on NFKB1 is unknown.
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(A)

(B)

Figure 20. View of NFKB1 genes and SNPs. (A) NCBI EntrezNucleotide View of
NFKB1 gene and mRNA transcripts. Markers indcate location of SNP: Purple:rs230530,
Red:rs160798. (B) Haploview generated LD map of the NFKB1 region in HapMap CEU
population. Regions of high LD (D=1 and LOD>2) are shown in bright red. Markers
with lower LD are shown in red (with D value indicated as a percentage) through pink
(decreasing color intensity indicates decreasing D value). Regions with high D values
but low informativeness (LOD>2) are shown in light blue. Regions of low LD and low
LOD scores are shown in white.

75

White Matter Candidate Gene
Neuroimaging, histological and gene expression studies suggest that myelin and
oligodendrocyte dysfunction contributes to the development of alcoholism. Genetic
studies have identified polymorphisms in several important regulators on myelination,
initiator of myelination MAG, and the transcription factor OLIG2, which are involved in
transcriptional and post-transcriptional regulation of the expression of multiple myelin
genes, respectively.
Myelin Associated Glycoprotein
GENE: MAG LOCATION: CHRM. 19
Myelin associated glycoprotein is a myelin specific transmembrane protein
believed to be important for the initiation and maintenance of the myelin sheath
(Schachner and Bartsch, 2000) as well as for maintaining oligodendrocytes and axons,
i.e. for synaptic stabilization (Davis et al., 2003). Several studies have reported that the
transcriptional regulatory elements are located in introns (Beohar and Kawamoto, 1998).
The gene consists of 14 exons within a span of 21.67kb and maps to chromosome
19q13.1 Studies have shown that postnatal ethanol exposure reduced the expression of
MAG isoforms in the cerebellum of animals in adulthood (Zoeller et al., 1994). This data
demonstrates that ethanol exposure, especially during the period of rapid myelination, has
selective effects on mRNA isoforms encoding MAG. Although numerous SNPs have
been identified, the functional impact on MAG is unknown (see Figure 21).
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Figure 21. Haploview generated LD map of the MAG region in HapMap CEU
population. Regions of high LD (D=1 and LOD>2) are shown in bright red. Markers
with lower LD are shown in red (with D value indicated as a percentage) through pink
(decreasing color intensity indicates decreasing D value). Regions with high D values
but low informativeness (LOD>2) are shown in light blue. Regions of low LD and low
LOD scores are shown in white.

Oligodendrocyte lineage transcription factor 2
Gene: OLIG2 Location: 21
Oligodendrocyte lineage transcription factor 2 is a basic helix–loop–helix
transcription factor and alcohol dependence might affect the expression of many other
OMR genes because it influences precursor (Lu et al., 2000) as well as fully matured
(Gokhan et al, 2005) oligodendrocytes and is both necessary and sufficient for the genesis
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of oligodendrocytes and myelination (Rowitch et al., 2002). Given its role as a master
regulator of oligodendrocyte lineages (Marshall et al., 2005), OLIG2 is a prime candidate
for hosting susceptibility SNPs with wide-ranging secondary effects on gene expression.
Although numerous SNPs have been identified the functional impact of these SNPs on
OLIG2 is unknown (see Figure 22).
(A)

(B)

Figure 22. View of OLIG2 genes and SNPs. (A) NCBI EntrezNucleotide View of
OLIG2 gene and mRNA transcripts. Markers indcate location of SNP: Purple:rs762178
(B) Haploview generated LD map of the OLIG2 region in HapMap CEU population.
Regions of high LD (D=1 and LOD>2) are shown in bright red. Markers with lower LD
are shown in red (with D value indicated as a percentage) through pink (decreasing color
intensity indicates decreasing D value). Regions with high D values but low
informativeness (LOD>2) are shown in light blue. Regions of low LD and low LOD
scores are shown in white.
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3.6

Statistical Analyses

3.6.1

Morphological Statistics
All gray matter volumes and white matter tract quantitative data was measured for

significance using a General Linear Model ANCOVA weighted by maximum drinks and
co-varied with the BDI-II score on SPSS. Graphing was completed using Graphpad
software for ease of editing and imaging.
3.6.2

Genotype Statistics
Genotypes of all subjects were identified using BeadStudio software. Calculations

of minor allele frequency (MAF) and Hardy Weinberg Equilibrium (HWE) were also
calculated using BeadStudio software. ADS L and ADS H individuals were compared to
one another in a 2 (ADS Group: Low vs. High) x 1(ROI) x 3 (Genotype: AA, AB, BB)
mixed factorial design. Significant interactions/correlations between significant ROIs
identified in Specific Aim 1 and 2 were found using Univariate Analysis of Variance on
SPSS.
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CHAPTER 4: RESULTS
4.1

Morphological Alterations in Gray Matter
Significant alterations in gray matter were seen between high and low AD

individuals. Specifically, the right caudate (F(1,39)=4.109, p=0.05, Figure 23) and the
right putamen (F(1,39)=5.199, p=0.028, Figure 24) of high AD individuals showed a
significantly larger volume than those of the low AD individual cohort. A significantly
smaller volume was seen in the left hippocampus (F(1,39)=5.786, p=0.021, Figure 25)
and left amygdala (F(1,39)=6.048, p=0.018, Figure 26) of high AD individuals, whereas
the left accumbens showed a significantly larger volume in high AD individuals
(F(1,39)=4.111, p=0.049, Figure 27).
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Figure 23. The right caudate of high AD individuals showed a significantly larger
volume than low AD individuals, (F(1,39)=4.109, p=0.05).
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Figure 24. The right putamen showed a significant larger volume in high AD individuals
than low AD individuals, (F(1,39)=5.199, p=0.028).
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Figure 25. The left hippocampus of high AD individuals showed a significantly smaller
volume than in low AD individuals, (F(1,39)=5.786, p=0.021).
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Amygdala
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Figure 26. The left amygdala showed a significantly smaller volume in high AD
individuals than low AD individuals, (F(1,39)=6.048, p=0.018).
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Figure 27. The left accumbens showed a significantly larger volume in high AD
individuals than low AD individuals, (F(1,39)=4.111, p=0.049).

4.2

Morphological Alterations in White Matter
Changes in the white matter of low and high AD individuals involved alterations

in volume and mean diffusivity.

Specifically, the cingulum bundle (gyrus aspect)

[F(1,32)=6.791, p=0.014, Figure 28] showed a significantly larger volume where as the
left corticospinal tract [F(1,32)=9.868, p=0.004, Figure 29] showed a significantly
smaller volume in high AD individuals. There was significantly lesser mean diffusivity
(MD), axial diffusivity (AxD) and radial diffusivity (RD) in the right uncinate fasciculus

84

[F(1,32)=7.071, p=0.012, F(1,32)=6.676, p=0.015,

and F(1,32)=4.120, p=0.050,

respectively, Figure 30] indicating a putative measure of better axonal integrity.
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Cingulum Bundle (gyrus aspect)
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(B) Cing. Bundle (gyrus) LOW AD

(C) Cing. Bundle (gyrus) HIGH ADS

Figure 28. (A) Left cingulum bundle (gyrus aspect) showed a significantly larger
volume in high AD individuals than low AD individuals. Images of a randomly chosen
low AD (B) and high AD (C) individual’s cingulum bundles (gyrus aspects) after DTI
tracking in DTIStudio.
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Corticospinal tract
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Figure 29. Left corticospinal tract showed a significantly smaller volume in high AD
individuals than low AD individuals (F(1,32)=9.868, p=0.004).
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Uncinate Fasciculus

Uncinate Fasciculus
0.00135

*

0.0010

0.00130

*
0.00125

0.0009

0.00120
0.0008

0.00115
0.00110

0.0007
R

L

R

R

L
High

Low

L
Low

R

L
High

Level of Alc. Dependence

Level of Alc. Dependence

*F(1,32)=6.676, p=0.015

*F(1,32)=7.071, p=0.012

Uncinate Fasciculus
0.0008

*
0.0007

0.0006

0.0005
R

L
Low

R

L
High

Level of Alc. Dependence
*F(1,32)=4.120, p=0.050

Figure 30. Right uncinate fasciculus showed less mean diffusivity (MD), axial
diffusivity (AxD), and radial diffusivity (RD) in high AD individuals than in low AD
individuals.

4.3

Candidate Gene Information and AD Individual Genotypes
The current study, using previously published genetic studies identified

polymorphisms in several genes important in neuronal growth and myelination. Specific
SNPs from GM and WM genes were chosen, resulting in the Table 3 and Table 4 which
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include SNP ID, location, alleles, minor allele frequencies, pathophysiologies and the
epidemiology with the AD cohort from the current study.
The genotype output from BeadStudio is also shown below with the major, minor,
and heterozygous allele count. It is interesting to note that for the rs6265 BDNF SNP, 41
of the 44 subjects carry the Met allele, see Table 5.
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Table 3. List of Genes and candidate SNPs chosen for the current study.
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Table 4. List of Genes and candidate SNPs chosen for the current study including the minor allele frequency from the CEU
database versus the AD cohort and the Hardy-Weinberg Equilibrium statistics from the CEU database versus the AD cohort.
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Table 5. Individual Genotypes of AD Individuals. This includes the low AD (blue),
high AD (orange), major, heterozygous, minor allele count, as well as total allele counts
(green).
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4.4

Associations
Exploratory associations found significant associations between two gray matter

structures and two SNPs was observed after univariate analysis of variance was
performed on gray matter structures that had significant alterations in volume and the AD
individual’s genotype (significance reported for ADS*SNP association, p<0.05). As seen
in the Figure 31, for Low ADS (“0” subgroup) to High ADS (“1” subgroup), carriers of
Val/Met genotype of the rs6265 BDNF SNP (“0”) show an association between level of
dependence [ADS*rs6265, F(1,43)=5.503,p=0.024] for the right amygdala volume,
whereas those individuals of the Val/Val (“1”) or Met/Met genotypes (“-1”) show no
effect of an association with level of AD. No significant association or conclusion can be
drawn about the Met/Met (“-1”) population because only three of the 44 subjects were
Met/Met. Also, for the right amygdala, an association is seen between low and high ADS
individuals that are T/T genotype (“-1”) of rs4304401 of the NTRK2 gene,
[ADS*rs4304401, F(1,43)= 5.343,p=0.026, Figure 32.] Note that there was a significant
trend towards an alteration in the right amygdalar volume between low and high ADS
subjects (Figure 26). Another significant association occurred in relation to the level of
dependence where major allele carriers of the SNP rs4304401 of the NTRK2 gene who
were high AD individuals had larger right accumbens volumes ADS*rs4304401,
F(1,43)= 5.324,p=0.026, Figure 33. Note that there was a significant trend towards an
alteration in the right accumbens volume between low and high ADS subjects (Figure
27).
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Although not significant, the results for rs6265 in the ROIs of the right accumbens
and left hippocampus and left caudate all show main effects of level of dependence, an
increase in volume and interestingly, being a Val/Met genotype, Figure 34.
White matter tract associations focus on the uncinate fasiculus radial diffusivity as
the significant ROI that shows a significant association in high AD individuals that are
G/G genotype, but no association was seen to the radial diffusivity in high AD
individuals who are A/G or A/A genotypes of the SNP rs3746248 of the MAG gene
(ADS*rs3746248, F(1,33)= 3.265,p=0.050), Figure 35.

Figure 31. Association of Amygdala X ADS level X SNP rs6265. An association was
indicated for heterozygous Val/Met carriers between low to high individuals amygdalar
volumes, (F(1,43)=5.503,p=0.024). “1”= Val/Val, yellow line, “0”= Val/Met, green line,
and “-1”= Met/Met, blue circle. X-axis, “0” indicates low AD, “1” indicates high AD.
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Figure 32. Association of Amygdala X ADS level X SNP rs4304401 in NTRK2. An
association was indicated for homozygous allele carriers between low to high individuals
amygdalar volumes, F(1,43)= 5.343,p=0.026. “-1”= T/T, blue line, and “0”= C/T, green
line. This population contained no C/C individuals. X-axis, “0” indicates low AD, “1”
indicates high AD.
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Figure 33. Association of Accumbens X ADS level X SNP rs4304401. Positive
correlation indicated for heterozygous allele carriers between low to high individuals
accumbens volumes, F(1,43)= 5.324,p=0.026. “-1”= T/T, blue line, “0”= C/T, green line.
This population contained no C/C individuals. X-axis, “0” indicates low AD, “1”
indicates high AD.
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Figure 34. Main effect of alcohol dependence and rs6265 of BDNF, not significant.
“-1”= Val/Val, blue line, “0”= Val/Met, green line, and “1”= Met/Met, yellow line. Xaxis, “0” indicates low AD, “1” indicates high AD.
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Figure 35. Association of Uncinate Fasciculus X ADS level X SNP rs3746248 of MAG.
An association was indicated for homozygous G/G allele carriers between low to high
individuals UF radial diffusivity, F(1,33)= 3.265,p=0.050. “-1”= G/G, blue line, “0”=
A/G, green line, and “1”=A/A, yellow line. X-axis, “0” indicates low AD, “1” indicates
high AD.
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CHAPTER 5: GENERAL DISCUSSION
5.1

Overview of major research findings
In this study, we used MRI and DTI to measure alterations in neuroanatomy of

alcohol dependent individuals and associated these findings with an individual’s
genotype for candidate SNPs to obtain information on biomarkers or susceptibility
markers for AD. It is well known that alcohol consumption has deleterious effects on the
human brain in older alcohol dependent individuals. In a younger cohort of individuals,
our analyses suggested an association between gray matter volumes and alcohol
dependence.

Given the young age of the cohort, this suggests that either alcohol

produces alterations early in the trajectory of dependence or it suggest that differences in
gray matter volumes may precede heavy drinking. In other words, some gray matter
volume differences may be a risk factor for alcohol dependence rather than a
consequence of alcohol dependence.
The limbic system consists of a network of cortical and subcortical regions that
mediate the effects of positive and negative reinforcement in addiction. And as such, the
system is central for sensory processing, stimulus reward associations, memory and mood
(Fuster et al, 2006; Goldman-Rakic et al, 1987). In this study, we used FSL based MRI
morphometry to measure volumetric brain alterations of numerous structures in low and
high alcohol dependent individuals. We tested the hypothesis that the gray matter within
certain regions of the reward network would be altered volumetrically in low versus high
AD individuals linking a behavioral category with an endophenotype. We observed that
several GM structures were significantly altered in volume between low versus high AD
individuals. These alterations were: in the high AD cohort, a significantly larger caudate
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putamen; a significantly smaller left hippocampus and amygdala; and in the low AD
cohort a significantly larger left accumbens.
DTI anisotropy and diffusivity measures derived from fiber tracking of selected
white matter fiber tracts and bundles enabled in vivo examination of the effect of low
versus high alcohol dependence on the microstructural integrity of major fiber bundles.
These data did not replicate earlier reports of macrostructural and microstructural
vulnerability of frontal regions to alcohol dependence by assessing FA of specific white
matter tracts and bundles (Pfefferbaum et al, 2008).
However, results showed a larger volume of the left cingulum bundle (gyrus
aspect) and a smaller volume of the left corticospinal tract of high AD individuals. The
most interesting finding, not previously published, was smaller values of the MD, AxD
and RD of the right uncinate fasciculus, which usually indicates better axonal integrity.
The results of Specific Aim 2 were exploratorty at best. With its multifactorial
design of 1 ROI X 2 levels of AD X 1 SNP, results demonstrated significant positive and
negative correlations between significant morphological alterations, level of AD and
specific SNP carriers. Specifically, in reference to right amygdalar volume, individuals
with the Val/Met genotype of the rs6265 BDNF SNP showed a positive correlation with
level of AD. Also, for the right amygdala, a positive correlation was seen between level
of dependence and individuals with the T/T genotype of the rs4304401 of the NTRK2
gene. Another significant positive correlation occurred in relation to the level of
dependence and individuals with the T/T genotype of the rs4304401 SNP of the NTRK2
gene for the right accumbens. Interestingly, the rs6265 SNP of the BDNF gene showed a
trend of a main effect within the low and high AD cohorts in several ROIs; right
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accumbens, left hippocampus and left caudate and an individual’s Val/Met or Met/Met
genotype..
White matter tract associations focused on the uncinate fasiculus as the significant
ROI in which a significant positive correlation was seen level of dependence and an
individual of the G/G genotype of the rs3746248 SNP found in the coding region of the
MAG gene. However this SNP, in which both forms G/G or A/A lead to the same
polypeptide sequence, is synonymous (silent mutation) resulting in the same amino acid
sequence of the MAG protein.
5.2

Interpretation of Results

5.2.1 Gray Matter Alternations
Prior structural neuroimaging studies in
alcoholism have focused primarily on global
alterations in cerebral cortex, white matter and
cerebellum,

and

additionally

in

the

hippocampus, demonstrating reductions in
volume in older alcoholics (Sullivan 2000;
Moselhy et al, 2001; Makris et al, 2008). There
is extensive connectivity among the amygdala and adjacent structures within the nucleus
accumbens region, structures that are part of the same neural system and these centers are
involved in associations between stimulus cues and reward (De Olmos et al, 1999).
Therefore, structural alterations in the caudate putamen, the accumbens and the amygdala
could influence the processing of rewarding stimuli, which is a central feature of alcohol
dependence (Kalivas & Volkow, 2005).
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We found a significant reduction in the volume of the amygdala of high AD in
relation to the low AD cohort, but an increase in the volumes of caudate-putamen and
accumbens in the high AD cohort supporting the claim that there may be a alterations in
the processing stream between the amygdala and the nucleus accumbens and the limbic
brainstem which then connects to the prefrontal cortex and cingulate cortex. The increase
in the volume of the caudate-putamen and accumbens is likely to influence connections
within this “stimulus/cue” or “reward system” of alcohol dependence.
Hippocampal and amygdala volume reductions have been previously reported in
alcoholics (Agartz et al, 1999) and reduced amygdala volumes were seen in adolescents
of high-risk alcoholism families (Hill et al, 2001). In our study, analysis of these critical
structures indicated that the left hippocampus and left amygdala were significantly
smaller in volume in those individuals that had a high level of AD, validating the study of
Makris et al, 2008. The fact that reduced volumes were observed in adolescents as well as
our younger cohort suggests the possibility that smaller amygdala volumes may precede
or develop very early in the trajectory of dependence. The connections of the amygdala
with other structures in this network, such as the prefrontal cortex, hippocampus and
accumbens are through its basolateral nucleus while the central nucleus is associated with
behavior modulating motivational influence of reward-related events (Swanson et al,
2003). It is unknown if the reduction was within the basolateral or central nucleus at this
time, but previous findings have indicated a loss of volume in the basolateral nucleus
(Makris et al, 2008) incriminating the reward-network. The brain reward system
implicated in the development of alcoholism comprises key elements of a basal forebrain
macrostructure, the amygdala, that includes the central nucleus of the amygdala, the bed
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nucleus of the stria terminalis, and a transition zone in the medial (shell) part of the
nucleus accumbens (Koob, 2003). The left amygdala volumetric decrease is known to
account for deficits in performance related to analytical aspects of memory, as well as
verbal memory (Aggleton et al 2000).
In 2009 Marinkovic et al., showed in alcoholics a deficient activation of amygdala
and hippocampus that underlies impaired processing of emotional faces associated with
long-term alcoholism and is a part of the wide array of behavioral problems including
disinhibition. In the alcoholic participants, amygdala activity was inversely correlated
with an increase in lateral prefrontal activity as a function of their behavioral deficits and
prefrontal modulation of emotional function. This inversion was compensation for the
blunted amygdala activity during a socially relevant face appraisal task was in agreement
with a distributed network engagement during emotional face processing. Marinkovic et
al study suggested that alcoholics might rely on prefrontal rather than temporal limbic
areas in order to compensate for reduced limbic responsivity and to maintain behavioral
adequacy when faced with emotionally or socially challenging situations. In this study
the smaller volumes of the amygdala and hippocampus may be reflective of lesser
activation demonstrated by alcoholics, suggesting behavioral disinhibition in AD.
It is unclear why the effect was lateralized (please see Appendix III). What is
currently known regarding lateralization of this pathway is limited. Structural brain
asymmetry and lateralization of functional dominance may result from molecular
regulation, neural connections, and plasticity (Anokhin et al, 2006).
This network is an integral part of the neurobiology of drug addiction in general,
and AD in particular (Koob et al., 1999). Structural malfunction in this system may
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increase risk for alcohol dependence leading to alcoholism and the abnormalities may
reflect a genetically influenced alteration in the trajectory of alcoholism (Begleiter et al,
1999). Although genetic factors connecting the asymmetry and functional pathways are
supported by this study, molecular correlates of this asymmetry are yet to be identified
(Sun and Walsh, 2006).
5.2.2

White Matter Alterations
The mechanism for low white matter FA in chronic alcoholics remains unclear

but most likely involves changes in myelination, axonal integrity, and accumulation of
extracellular fluid observable best at the microstructural level. FA is a common measure
to show WM damage in alcoholics or AD individuals (Pfefferbaum et al, 2008). No
significant decrease in FA was seen between low AD versus high AD individuals in the
present study, contradicting numerous previous studies that have shown severe damage in
the white matter tracts of alcohol dependent individuals. However, previous studies have
focused on life time consumption of alcohol with larger sample sizes and an average age
between 40-50 years (Pfefferbaum et al, 1992, 2008; Gazdzinski et al, 2005). Our
research focused on alcohol dependency in individuals 21-30 years of age, individuals in
the first stages of AD, and a quarter of the sample size, n=45. This also suggests that
white matter alterations are not likely to represent a premorbid risk factor, but in fact,
may be a consequence of long-term alcohol abuse.
Significant results were seen in the more sensitive measure of white matter, mean
diffusivity, which can be broken down into axial (AxD) and radial diffusivity (RD). Of
great interest was the fact that out of 11 white matter tracts measured, only one tract, the
right uncinate fasiculus (UF), showed an alteration in high AD individual cohort.
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The

UF, which connects the limbic system, such as the hippocampus and amygdala, in the
temporal lobe with the frontal lobe such as the orbitofrontal cortex, showed a significant
decrease in MD, AxD and RD of high AD individuals. This significant decrease in the
MD value means better diffusion of the water molecules along the longitudinal (axonal)
axis, indicating better axonal integrity. When looking at the other two measures, the
decrease in AxD indicates an increase in the rate of diffusion along the orientation of the
fibers in the UF. This decrease in axial diffusivity may be related to the growth of
neurofibrils, such as microtubules and neurofilaments, that would increase the tortuosity
of the extra-axonal space. Conversely, the destruction of neurofibrils has been found to
increase axial diffusivity (Kinoshita et al., 1999). Other factors, which have been
proposed to affect axial diffusivity, include fiber coherence (Dubois et al., 2008), and
axonal injury, which in animal studies is associated with reduction in axial diffusivity
(Kim et al., 2006).

The decrease in the RD demonstrates a strengthening in the

magnitude of the diffusion in the plane transverse to the axonal bundles and may reflect
primarily, but indirectly, the myelination process. Therefore, it is likely that changes in
the different measures of diffusivity reflect complex interactions of multiple biological
factors that drive it in the direction of better axonal integrity. This suggests that a
neuroadaptive effect related to the alcohol dependence may exist in this age group in the
right uncinate fasciculus.
Other significant results included a larger volume (number of voxels) of the left
cingulum bundle gyrus aspect in high AD individuals in relation to the low AD cohort.
The gyrus aspect of the cingulum bundle interconnects parts of the limbic system. It
originates within the white matter of the temporal pole, and runs posterior and superior
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into the parietal lobe, then turns, forming a belt around the corpus callosum, into the
frontal lobe, terminating anterior and inferior to the genu of the corpus callosum in the
orbitofrontal cortex (Schmahmann and Pandya, 2006). Functionally, the gyrus aspect is
involved in executive control and dysfunction in substance dependent individuals
(Verdejo-Garcia, et al., 2006). In this study substance-dependent individuals (SDI)
(including alcohol, cocaine, and methamphetamine polysubstance users) were compared
with healthy controls on a series of behavioral (Frontal Systems Behavior Scale, FrSBe),
cognitive (N-back, Go-No Go, and Wisconsin Card Sorting Tasks), and emotional
(International Affective Picture System, IAPS) tasks, each of which was thought to tax a
different component of these PFC functional systems. The results indicated that SDI
showed greater behavioral problems in the apathy, disinhibition, and executive
dysfunction and behavioral deficits were significantly associated with several real-life
domains in which SDI typically have problems. Also, SDI also showed poorer
performance on cognitive tests of working memory, response inhibition and mental
flexibility, and abnormal processing of affective images (Verdejo-Garcia et al, 2006).
This study shows evidence that substance-dependent individuals (SDI) are impaired in
executive control tasks relying on different systems within the prefrontal cortex (PFC)
which consists of three different functional systems: the dorsolateral prefrontal cortex
(DLPC), orbitofrontal cortex (OFC), and anterior cingulate cortex (ACC) circuits.
Dysfunction within each PFC system is associated with different behavioral, cognitive,
and emotional abnormalities. Previous studies have also shown the cingulum bundle to
decrease FA (demyelination) in depression and schizophrenia (Kubiki et al, 2003; Wang
et al, 2004). In light of the current findings, the significantly larger left gyrus aspect of
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the cingulum bundle, running from the genu to the splenium of the corpus callosum, may
simply indicate that there is no impairment in executive control tasks within this age
cohort although they are dependent on alcohol.
The left corticospinal tract in this study was significantly smaller in the
individuals with high AD.

Anatomically, the corticospinal tract originates from

pyramidal cells in layer V of the cerebral cortex and half of its fibers arise from the
primary motor cortex. Other contributions to the tract come from the supplementary
motor area, premotor cortex, somatosensory cortex, parietal lobe, and cingulate gyrus.
One previous study has shown low FA and high MD in cortico-striatal fibers providing
evidence of compromised integrity of the motor circuitry in alcohol use disorders (Yeh et
al, 2009).

Specifically, we show a smaller volume of the left CST of high AD

individuals, this may be a precursor to future motor disabilities that develop with
increased substance abuse.
The current results support a ROI specific pattern, rather than a uniform and
global distribution, of compromised gray and white matter not seen in previous studies.
Within the 21-30 year cohort, it may be possible that the brain is somewhat resilient to
the damaging effects of alcohol, but showing the beginnings of neuroadaptive alterations
with increased alcohol dependence.
5.2.3

Significant Genetic Associations
In general, there were an insufficient number of subjects to conduct meaningful

analyses or correlations of the candidate SNPs. Exploratory analyses on the association
between specific SNPs and brain structure were conducted in both the high and low AD
groups. A number of significant associations were observed. A significant association
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was seen for those individuals that were Val/Met of the rs6265 SNP and level of
dependence.
Another significant and interesting association was seen between low and high
AD individuals and the T/T rs4304401 SNP found in the NTRK2 gene within the
amygdala. This data indicates that the major T/T allele shows a positive correlation with
the level of AD as a protective SNP. The same SNP, rs4304401, has an association in the
accumbens in which the T/T allele, again, shows a positive correlation with the level of
dependence. The SNP is intronic and the gene itself is the cognate receptor for BDNF,
the results show a normal distribution of the major T/T allele suggesting normal function
of the TrkB receptor protein. Also, these results suggest that as a T/T genotype carrier
there is a likelihood of becoming increasingly dependent on alcohol.
The discovery that genetic variation in both the BDNF gene and its cognate
receptor TrkB gene show associations with level of AD in the amygdala and accumbens
is noteworthy. Main effects of alcohol dependence and being a Val/Met genotype was
seen in the associations suggesting that this SNP may influence not only morphology, but
also a susceptibility to alcoholism. The BDNF SNP has been implicated in numerous
genetic association studies to neuropsychiatric diseases and carries with it a
pathophysiology that is damaging to neurons seen in in vitro animal studies (Matsushita
et al., 2004; Egan et al., 2003; Hariri et al., 2003). Therefore, the Val/Met carrier may
have a predilection for altered gray matter volumes, in the amygdala, hippocampus and/or
accumbens (Appendix IV). This may indicate a heightened risk or susceptibility to
becoming alcohol dependent, although, without a comparison to untreated controls a
formal conclusion cannot be drawn.
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A significant relationship was also seen in the radial diffusivity of the uncinate
fasciculus between level of AD individuals and the SNP rs3746248 found in the coding
region of the MAG gene. Specifically, the G/G genotype individuals do not show any
amino acid changes associated with the initiation and maintenance of myelination as well
as synapse stability. Together this association data from the significant white matter
alteration in RD to the SNP to the level of dependence suggests that a carrier of the
rs3746248 SNP in the MAG gene may be demonstrating myelination and protection
during the neuroadaptation as risk of alcohol dependency increases.
The significant relationships seen in the present study indicate that genetic,
endophenotypic and neuroimaging data can be combined to a certain extent in a
translational framework. This study differs from prior investigations in three aspects.
First, it sees the structures as related to an interconnected system in a “big picture,” that
treats the gray and white matter structures as a group of regions, but still individually in
statistical analyses. Second, several structures in the current study have not been
measured or studied in prior neuroimaging studies of alcohol dependent individuals.
Third, correlations associating the morphometry defined by behavioral tests and genetic
makeup performed were not seen previous studies.
5.2.4

Effect of Age on Nueroanatomical Structures
Brain structural changes become more prominent with aging (Pfefferbaum et

al., 2005; Sullivan et al., 1995; Oscar-Bermann et al., 2000), and alcoholism can
exaggerate age-related volumetric reductions (Pfefferbaum et al., 1997; Kubota et al.,
2001). There is a well-known and well-documented effect of aging and the alteration
of volumes of certain structures within the human brain, yet all these studies focus on
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affects starting at an average age of 40 years (Pfefferbaum et al., 1997). The original
age criteria for our study was a cohort of 192 subjects, 21 to 50 years of age. Upon
ranking and defining low and high alcohol dependent individuals, obtaining and
analyzing gray matter volumes, a significant positive correlation of age was seen
between level of AD and age (Figure 36). This suggested that the older an individual
the greater the level of dependence on alcohol, which follows a common thread of
logic in alcoholism. Due to this positive correlation we proceeded to analyze the
individuals by a specific age subset, and for this study we focused on 21-30 years of
age. This age group has not been studied in depth and spans a developmental period in
which alcohol dependence begins and takes root.
Ge et al. in 2002, show age-associated patterns of change in GM and WM
volumes at a global level. The decline in percent of GM starts to occur at a relatively
young age (mid-20s), and the decrease is slight, but constant and linear (Figure 37).
The percent white matter, in contrast, shows a quadratic pattern of change, slightly
increasing until an age of approximately 35 years, decreasing quickly thereafter
(Figure 37, Ge et al., 2002). Adolescent maturational changes in the gray matter
occur in spatially and temporally specific patterns, with parietal cortices maturing
earlier than frontal cortices (Sowell et al., 1999) and in normal adults, using voxelbased morphometry (VBM), gray matter loss with aging is most prominent in the
insula and superior parietal gyri (Good et al., 2001). Longitudinal studies show that
gray matter volume increases in early childhood and then declines after puberty (Giedd
et al., 1999), and white matter volume progressively increases (Sowell et al., 2002). A
decline in gray matter volume is prominent between adulthood and old age, whereas
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white matter volume increases between 19 and 40 years, after which it steadily
declines (Jernigan et al., 2001). Specifically, in the Sowell et al., 2003 study of 142
subjects scanned for cortical changes across a lifespan, there was a subtle increase in
gray matter density until age 30, which remained stable until a precipitous decline in
later decades and the cingulate gyrus showed no rapid loss as well. Taking this
information into account, our study showed larger volumes in the caudate, putamen,
accumbens suggesting that the neuroadaptative phase of alcoholism is working against
the effects of aging in the high AD cohort, a preservative effect. Unfortunately, most
of these studies focus on decreases in global gray matter and white matter, in the
cortical regions, and our study focused on gray matter structures with in the
limbic/reward system.
To address controversies regarding the effect of age on the hippocampus,
volumes of hippocampus and a control structure, the temporal cortex, were measured
on magnetic resonance imaging (MRI) in 128 healthy individuals (20-85 years)
(Pfefferbaum et al., 2005). Individuals in this study showed no significant correlations
between hippocampal volumes and age, despite significant age-related decline in
temporal volumes. A VBM study conducted by Good et al., 2001 of 465 normal adult
human brains also demonstrated little or no age effect in the amygdala and
hippocampus. The smaller volume of the hippocampus and amygdala of the high AD
cohort in our study indicates an effect of AD not of aging.
Cerebral white matter changes throughout the lifespan. It’s volume increases
from childhood to young adulthood, remains stable during middle age, and shrinks in
senescence (Hasan et al., 2008).

DTI studies of normal aging show that the
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microstructural integrity of WM is also reduced with age, with greater differences
observed in the anterior and posterior regions (Pfefferbaum et al., 2000, 2005).
Changes of DTI indices were found to continue from late childhood to young
adulthood, and were more widespread between early adolescence and young adulthood
than between late childhood and early adolescence. Although this difference may be
partly accounted for by the smaller age difference between late childhood and early
adolescence, than early adolescence and young adulthood, the finding is consistent
with a previous report which also showed more widespread FA increase between
childhood and young adulthood groups than within the childhood group (Snook et al.,
2005). Structural imaging studies have similarly demonstrated prominent brain growth
during this period rather than earlier in childhood (Sowell et al., 2001). These findings
during the period when complex cognitive functions such as executive function and
attention are maturing suggest that these developments may be the neural substrate of
maturing cognitive functions. Our study found a larger volume of the cingulum
bundle gyrus aspect in high AD cohort suggesting that the morphological alteration
may be an effect of aging and/or alcohol dependence, although this cannot be
quantified properly. The corticospinal tract showed a smaller volume in the high AD
cohort indicating that the alteration was accelerated loss due to alcohol dependence
and not aging. The lesser value of the mean diffusivity, axial diffusivity and radial
diffusivity, of the right uncinate fasciculus in the high AD cohort, which indicates
better axonal integrity or strengthening of the connectivity between the temporal lobe
and the posterior orbitofrontal cortex, suggests an effect of aging and maturation that
occurs between 21-30 years of age.
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Our data provides evidence of effects of aging, although slight, between the
ages of 21-30 years, when looking at white matter maturation. The global decrease in
gray matter density however does not compare with the larger volumes seen in the
high AD cohort.
(A)

(B)

(C)

Figure 36. Age X AD correlation. (A) Population distribution. (B) Multivariate tests
performed. (C) Pearson Correlation indicating a significant positive correlation
between age and ADS level of dependence, r2=0.422.
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Figure 37. Regression analysis of fractional brain tissue volume estimates on 54 healthy
adult subjects. Linear and weighted constrained quadratic models are presented; these
indicate the age-related volume estimates throughout adulthood in normal brains. (A)
%GM (B) % WM. (Ge et al., 2002)

5.2.5

Lateralization in the Brain of the Young Adult
The hemispheres of the human brain are functionally and structurally

asymmetric. The analysis of structural asymmetries is of great use in identifying the
neuroanatomical basis of disorders with a presumed developmental etiology, such as
dyslexia, autism, and schizophrenia (Crow, 1990; Filipek, 1995). The underlying
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assumption in such studies is that abnormal brain development may result in atypical
asymmetries, which in turn are related to abnormal functional organization and
behavior.
In the Wakana et al., 2008 study, which defined the construction protocols for
studying white matter tracts, a normal population was measured in which the averaged
sizes of fibers for 10 healthy volunteers can be seen in Figure 38. The reconstructed
tracts tend to be larger in the left hemisphere and the differences are significant for the
cingulum bundle gyrus aspect, superior longitudinal fasiculus temporal, inferior
longitudinal fasiculus, and uncinate fasiculus, while no difference is found for the
corticospinal tract and inferior fronto-occipital fasiculus. Interestingly, all asymmetric
tracts are related to the temporal lobe, but no conclusion was drawn by Wakana et al,
2008 about the asymmetry in the size of the fibers in the temporal lobe, or which
regions of the lobe account for the alterations. The asymmetry of the cingulum (Gong
et al., 2005) and the superior longitudinal fasiculus (Makris et al., 2005, Nucifora et
al., 2005) has been reported in multiple publications.
Our study showed a larger volume of the left cingulum bundle gyrus aspect,
and a smaller volume of the left corticospinal in high AD individuals. The current
study did not have a “normal, healthy, control” cohort and as such, by comparing to
Wakana et al., 2008 data, some conclusions as to lateralization can be drawn even
though the scales (mm3 vs. # of voxels) are different. Looking at the cingulum bundle
gyrus aspect (CGC), in normal healthy volunteers the left CGC aspect is significantly
larger in volume and in our study both low and high AD individuals show this trend.
This suggests that the significantly larger volume of the CGC in high AD individuals
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may be linked to neuroadaptive changes occurring due to alcohol dependence. The
corticospinal tract (CST) of normal healthy individuals showed no lateralization
between right and left, yet in our study low AD subjects showed a larger left CST,
which in the high AD cohort was significantly smaller and was the same volume as the
right CST. This suggests that low alcohol dependence may be a phase in which
neuroadaptation is occurring, and as level of alcohol dependence increases, the CST is
subject to degeneration leading it back to the same volume as the right CST as seen in
the normal individual. The larger volume of the CST in the low AD cohort may
indicate the “neuroadaptation” phase, while the smaller volume of the CST in the high
AD may indicate the decrease in motor function seen alcoholic individuals.
In 2001, Watkins et al., measured 142 normal human brains using MRI, with
an average age of 24.8 years, that the caudate shows R>L lateralization and the
putamen shows L>R lateralization. Although actual data are unknown, in our study
the right caudate in both low and high AD individuals showed a trend towards R>L
asymmetry.

The larger volume of the right caudate between low and high AD

individuals, then demonstrates an increase that is not due to lateralization but instead
to the effects of alcohol dependence and the neuroadaptation occurring at this time
point. Looking at the putamen, in our study, the left putamen reflected the L>R
lateralization found in normal control individuals in low and high AD individuals. The
significantly larger right putamen in the high AD cohort may be a reflection, again, of
some compensatory mechanism of neuroadaptation during the gradually increasing
dependence on alcohol.
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The hippocampus has been see to have R>L asymmetry in healthy individuals
(N=40, average age = 25.5yrs) as does the amygdala (N=20) (Pruessner et al, 2000;
Filipek et al, 1994). In our study this asymmetry was not seen in the low AD cohort,
where the volume of the right and left hippocampus were very similar. In the high AD
cohort, the lateralization was reversed significantly in that the left hippocampus
volume was significantly smaller than that of the right. This suggests that that the loss
in volume in the left hippocampus is drastic and severely affected by AD. The
amygdala also reflects the same path as the hippocampus in that the low AD cohort
shows no lateralization, and the high AD cohort has a significantly smaller left
amygdala. This suggests, also, that the loss in volume in the left amygdala is large and
is affected by AD.
In 1998, Baumann and colleagues, in a preliminary study of eight control postmortem brains, identified a L>R lateralization of the accumbens. No data could be
found on the lateralization of the accumbens in the young adult brain. Based on the
Bauman study, our data shows no such lateralization. In the low and high AD cohort,
the left accumbens has a smaller volume than the right and the significantly larger
volume of the high AD cohort suggests a simple compensatory mechanism of
neuroadaptation due to a higher level of AD.
In conclusion, without a control group in our research on which to base these
comparisons, no final claims can be drawn as to whether there is an affect of AD on
the lateralization of certain structures and whether this emphasis is R>L or L>R.
There is in involvement of multiple brain regions in alcohol dependence and a larger
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cohort, along with normal healthy control individuals would increase our
understanding of the influence AD may have on lateralization.

Figure 38. Sizes of white matter tracts of 10 healthy volunteers. Averages and standard
deviations shown. Asterisks indicate statistically significant difference with p<0.05. R
and L indicate right and left hemisphere. CGC, cingulum gyrus; CGH, cingulum
hippocampal; CST, corticospinal tract; ATR, anterior thalamic radiation; SLF, superior
longitudinal fasiculus; SLFt, superior longitudinal fasiculus temporal; ILF, inferior
longitudinal fasciculus; IFO inferior fronto-occipital fasciculus; UNC, uncinate
fasciculus; Fmaj, forceps major; Fmin, forceps minor.

5.3

Future Directions
Future studies are being developed to build on the current findings. In order to

better understand whether structural differences are a premorbid risk factor versus a
consequence of alcohol abuse, a prospective study with longitudinal follow-up measures
of structure and alcohol use need to be conducted. Ideally, these studies will examine the
progression of structural changes and alcohol use, beginning in adolescent, through midlife. In addition, the present study only focused on SNPs in candidate genes. With a
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sufficient sample size, future studies will be able to conduct genome wide analyses. In
addition, other forms of genetic variation should be examined in future studies. Recently,
rare structural variants--copy number variants (CNVs)—which correspond to micro
duplications or micro deletions of 110kb at least leading to duplicate or disrupted genes,
were identified by comparative genomic hybridization in several psychiatric disorders
such as schizophrenia (Sebat, 2007; Cantor et al., 2008).
Another developing area of research that should be integrated with brain-based
phenotypes is epigenetics. Complex epigenetic mechanisms that regulate gene activity
without altering DNA have been shown to produce permanent changes in gene
expression, both in cell differentiation and adaptation to environment. Mechanisms such
as DNA methylation, post-translational histone modification, nucleosome sliding can
cause modifications of chromatin conformation which regulate gene expression
(Tsankova et al, 2007). Chromatin remodeling can be studied at the single locus level
however, current methods, such as chromatin immunoprecipitation in combination with
DNA sequencing (ChIP-seq) allows for genome wide analysis (Ducci and Goldman,
2008).

Alcohol exposure has been shown to cause changes in chromatin structure

(Mahadev et al, 1998).

Recently, an increase in alpha synuclein promoter DNA

methylation has been found in patients with alcoholism (Bonsch et al, 2005). Epigenetic
variation within the human SNCA gene has been linked to alcohol craving (Foroud et al,
2007) and the gene maps to a QTL for alcohol preference and expression has been seen to
increase in different brain areas in rats displaying alcohol preference (Liang et al, 2003)
all indicating that DNA methylation also appears to regulate expression of certain genes
in alcoholism.
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It is important to note that the majority of the studies to date have focused on
populations of European ancestry. An additional challenge is to examine AD risk from
other population perspectives.

There is already considerable data supporting risk

differences by population and some risk alleles are known to be population specific
(Ducci and Goldman, 2008). Studies on genetically isolated population, such as Native
American populations, are very promising due to the high homogeneity of the genetic
background, and in this case, high prevalence of alcohol dependence (Compton et al.,
2007).

Linkage analysis in Native Americans provided evidence for loci on

chromosomes 5, 6, 12, 15 and 16 (Ehlers et al., 2004), and allowed the identification of
GABA receptor genetic variants as a risk for alcohol dependence (Radel et al., 2005).
Future studies may also need to employ difference approaches to the analyses of
the imaging data. Voxelwise analyses based on an initial alignment of the diffusion data
to a standard brain image, spatial smoothing and then voxelwise cross-subject analysis of
the resulting aligned data is often referred to as voxel-based morphometry (VBM). There
has been much debate about the limitations of such an approach, primarily because there
can be ambiguity as to whether apparent changes are truly due to change in gray matter
density or simply due to spatial misalignment. With the advent of new algorithms,
programming, and software, white matter fiber tracking has also advanced in the field of
neuroimaging and quantification. Tract-based spatial statistics (TBSS) is an automated
observer-independent method of aligning fractional anisotropy (FA) images from
multiple subjects to allow groupwise comparisons of diffusion tensor imaging data. The
new method, TBSS, aims to solve issues involving misalignment via (a) carefully tuned
non-linear registration, followed by (b) projection onto an alignment-invariant tract
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representation (the “mean FA skeleton”). It aims to improve the sensitivity, objectivity
and interpretability of analysis of multi-subject diffusion imaging studies (Smith SM et
al, 2007). The primary advantage of voxelwise analyses compared to tractography-based
analysis, used in the current research, is that the entire brain can easily be investigated in
a fully automated manner, without having to specify in advance regions of interest or
delineate, which done by hand and is time consuming, the specific tracts to measure.
However, voxelwise analysis such as TBSS does not directly provide information on
long-range structural connectivity in the brain, but is limited to investigating local
changes in the white matter structure. It should not, therefore, be used as a replacement
for careful tractography-based connectivity analysis of DTI data, which should ideally be
used in conjunction with a voxelwise analysis (Smith SM et al., 2007).
Currently there are numerous advances in molecular biology, neuroimaging,
genetics and psychopathology, and opportunities arise to study the interplay of genes,
brain and behavior within a translational framework. This strategy, in which genetic
effects on brain function can be explored using neuroimaging, is somewhat new at
present and has been titled “Imaging Genetics (IG)” (Viding et al., 2006). The flow of
knowledge within the field of IG includes identifying specific genes that contribute to
risk for illnesses that then provide critical information on the causes of these diseases,
which then may lead to the development of fresh diagnostic and therapeutic strategies.
The present study adds to the mounting evidence that this approach can be an effective
means of identifying genetic variation that influences brain based phenotypes which in
turn may influence the risk for alcohol dependence.
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5.4

Limitations and Critique
In general, there are numerous caveats that exist in a translational framework.

The combination of three different fields of science has its advantages and disadvantages.
For example, despite the significance of integrating genetic and neuroimaging data, there
are several caveats--for a marker to be considered an endophenotype, it must be shown to
(1) be highly heritable, (2) be associated with the phenotype, (3) be independent of a
clinical state, and (4) impairment must co-segregate with the illness within a family
(Gershon and Goldin, 1986; Glahn et al, 2004). Taking all of these categories into
account, the current study doesn’t demonstrate the heritability of the endophenotypes
because the study is not familial but associative.
5.4.1

Depression
In the present study depression, indicated by the BDI-II scale score, was a co-

variate during statistical analysis because of its comorbidity to occur along with
alcoholism, demonstrated by Merikangas and Gerlernter in 1990. Many people with
alcohol problems spend a substantial portion of their lives drinking and thus have less
opportunity to demonstrate independent episodes of depression. An alcoholic with true
vulnerability for depression may, by natural course of the two illnesses, have no seen
independent episodes (Nurnberger JI et al., 2002). Thus, although the interpretation of
the linkage results (of the COGA study by Nurnberger JI et al., 2002 in Chapter 2,
Section 3.2) in complex diseases is the subject of the ongoing controversy, it appears that
a locus on chromosome 1 accounts for some of the familial aggregation of alcoholism
and depression. None of the SNPs in this study are located on chromosome 1, where
alcoholism and depression co-occur, indicating that there may not have been a need to
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co-vary for depression in the statistical analysis, even though a significant positive
correlation existed between the ADS scale score and the BDI-II scale score. To follow
up on this, both diseases have different underlying mechanisms as well. The findings
suggest that one or more genes are associated with different clinical phenotypes, or are
pleiotropic. The BDNF gene and its Val66Met SNP rs6265, which causes a dysfunction
in protein trafficking, have been implicated in depression and schizophrenia as well. In
disorders to which multiple genetic factors contribute but for which no single factor is
absolutely necessary, evidence for specific effects can differ among different data sets. A
replication study is needed with data sets of a size equivalent to the original data set or
the current data set could test depression as its own variable for interactions with
morphological alterations and correlations to genotype. The current study suggests a
relationship between depression and alcohol dependence in an associative study and is
consistent with previous findings (Nurnberger et al., 2002; Merikangas et al., 1994).
5.4.2

Population Stratification
This is the presence of a systematic difference in allele frequencies between

subpopulations in a population possibly due to different ancestry, especially in the
context of association studies. In this study, AD L and AD H individuals were compared
to one another in a 2 (AD Group: Low vs. High) x 1 (ROI) x 3 (Genotype: AA, AB, BB)
mixed factorial design. One major concern with this design is that any group differences
at the genetic level should not be misinterpreted as a spurious association because the
population is stratified into sub-populations (e.g. age, gender, nicotine addiction, BMI,
etc) that were not used in the analysis. To reduce this effect, methods can be developed
and implemented to test and statistically control for this potential bias. Because the
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population stratification may bias the results, and the frequency of the major and minor
alleles does not reach Hardy-Weinberg Equilibrium in the current subject population,
recent publications suggest methods to control Type I errors due to population
stratification (review by Hutchison, Stallings, McGeary, & Bryan, 2004). The proposed
method uses extra highly polymorphic markers to generate a generic estimate of
population stratification that is then used to adjust the statistical test for association
between the candidate marker and the outcome variable. With this in mind, one could
use a set number of highly polymorphic markers, compute a χ2 on each marker, and form
a collective χ2 to test for genetic differences across the ADS individuals (Pritchard &
Rosenberg, 1999). If population stratification is seen in the cohort, further analyses of the
SNP could be adjusted depending on the direction of the bias.
Sample Size
Genetic studies typically require large sample sizes (200-3000 subjects) and to
detect even medium to small gene effects.

In contrast, most neuroimaging studies

include only 10-20 subjects. Such small studies require a strong prior hypothesis lacking
in complex disease genetics and ascertainment strategies to have any chance of detecting
a significant correlation. This disparity in sample size is a point of friction between
traditional genetics and traditional neuroimaging. Functional neuroimaging data may
represent a final common pathway for neuronal activity before it is transformed into a
behavior as proposed by Hariri and Weinberger (2003).

In this case, functional

neuroimaging data could be significantly more sensitive to gene action than over
behavior and thus far smaller sample sizes may be needed to detect activity using
neuroimaging data than behavioral data. To date, the hypothesis involving AD linking to
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a handful of candidate SNPs has only been tested by the present study and showed no
conclusive results due to the small sample size. The number of subjects needed for
imaging genomic studies is a controversy and an open debate.
Data Complexity
Both imaging and genetic data are complex, each with million of possible
variables and the potential for spurious findings.

To minimize computational

requirements and to limit the number of potential statistical tests, many researchers
reduce the imaging data to a small number of scalar values per subject (e.g. hippocampal
grey matter density or amygdale activation). This was seen in the current study within
Specific Aim 1, dealing with each subjects ROI measurements. Also, a small subset of
available genetic information focusing on a single SNP or haplotype was also used in
Specific Aim 2. Data reduction procedures are necessary because Type I error control is
not yet available. Unfortunately, by significantly reducing one or both types of data,
important relationships are lost as seen in the present study. Thus, the development of
multi-dimensional procedures to allow whole genome-full brain analyses is necessary.
Measurement Reliability
Large scale genetic studies apply methods to determine the reliability and validity
of each sample being processed (e.g. SNP consistency, gender matching) and procedures
to minimize potential genotyping error. These methods are not applied in neuroimaging
data, though quality and quantification procedures typically reduce error related to data
acquisition and analysis. Most neuroimaging studies require significant post-processing
to render raw data into behaviorally or genetically meaningful information (e.g.
hippocampal demarcation, amygdalar maps of fMRI activation). However, the reliability
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of these measures is generally not provided. Many neuroimaging measurements are quite
reliable (Specht et al., 2003), nevertheless the relative reliability across individuals or
over time of specific dependent measures should be considered when choosing measures
to apply in genetic analysis.
5.4.3

Gene-by-Environment (GxE) Interactions and AD
With the heritability of AD in the range of 50-60%, there is considerable

environmental influence on the phenotype, which is common for complex trait diseases.
However, environmental factors weigh heavily and may be a necessary component of
AD, see Figure 39. An individual cannot become dependent without exposure to the
substance, regardless of genetic makeup. The impact of environmental factors on genetic
risk of AD related to alcohol metabolizing enzymes has a very long history. At present,
GxE effects can be detected reliably using behavioral assessments and specific candidate
loci.
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Figure 39. Main and interactive effects of genetics and environmental risk factors for
alcoholism (Ducci and Goldman, 2008).

5.5

Summary and Conclusion
Alcohol dependence is a complex addictive disorder, affecting 5.4% of the

general population during a lifetime (Kessler, 2005) and represents a complex
heterogeneous phenotype, with behavioral, as well as psychological, pharmalogical and
genetic components.
This research focuses on a translational framework on current studies of alcohol
dependence and the combined fields of genetics and neuroimaging. After assessing the
differences between low and high alcohol dependent individuals using ADS scale derived
from DSM-IV, morphological changes in the neuroanatomical structures, gray and white
matter, were identified.

The use of neuroimaging measures as endophenotypes for
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psychiatric illnesses could lead to new gene discoveries, and a better understanding of the
mechanisms involved in these disorders.

The application of imaging measures in

molecular genetic investigations could significantly improve our understanding of brain
function and structure.
This genomic functional approach was combined with the endophenotypes to
narrow the associated gene, or biomarker, identifying a specific step in the pathway to
AD. After an overview of genetic research on AD, including genome wide scans and
candidate genes analyses, the genotypes of the AD individuals were obtained and
correlated.
The study of AD has a long extensive history and has seen new breakthroughs and
revisions of previous research in the past decade in the aspect of genetics and
environment with the advent of new imaging and genetic analysis techniques.
The present research shows evidence that behavioral diseases are associated with
identifiable neuroanatomic alterations, and do form relationships with specific SNPs.
Additional information is needed when studying a specific, yet multifactorial disease,
such as AD, but nonetheless, we advocate the use of neuroimaging measures in genetic
studies. This type of translational research will significantly advance our understanding
of systems level neuroscience and brain-related disorders.
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APPENDIX I: DTISTUDIO METHODS FOR WHITE MATTER
TRACTOGRAPHY
Construction Protocols (Wakana et al., 2008)
Cingulum Bundle Gyrus Aspect

Location of the ROIs for the cingulum in the cingulated gyrus aspect (cgc) on two
coronal slices (a and c) and their locations in the mis-sagittal slice (b and d). The SCC
and GCC stand for the splenium of the corpus callosum and the genu of the corpus
callosum, respectively.
Cingulum Bundle Hippocampal Aspect

Location of the ROIs for the cingulum bundle hippocampal aspect (cgh) on two
coronal slices (a and c) and their locations in the mid-saggital slice (b and d).
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Corticospinal Tract

Locations of the ROIs for the corticospinal tract (CST) on two axial slices (a and c)
and their locations in the mid- sagittal slice (b and d). The first ROI is drawn on the
cerebral peduncle at the level of the decussation of the superior cerebellar peduncle
(dscp). From the tracking seen above, the central sulcus (cs) and the projection to the
motor cortex is identified. Using the axial slice right after the bifurcation to the motor
cortex, the cst is selected.
Anterior Thalamic Radiation

Locations of the ROIs for the anterior thalamic radiation (atr) on two coronal slices (a
and c) and their locations in the mid-sagittal slice (b and d). IC, internal capsule.
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Superior Longitudinal Fasciculus

Locations of the ROIs for the superior longitudinal fasciculus (slf). At the middle of
the posterior limb of the internal capsule (plic), a coronal slice if selected (b). The slf
can be identified as an intense triangle shaped green structure. The first ROI is shown
in (c:coronal) and (d: sagittal). For the second ROI, a coronal slice is selected at the
splenium of the corpus callosum (f).
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Inferior Longitudinal Fasciculus

Locations of the ROIs for the inferior longitudinal fasciculus (ilf). First a para-sagittal
slice (b) is identified at the level of the cingulum (a, cg). The parieto-occipital sulcus
(pos) is identified in the sagittal plane. A coronal slice (c and d) is selected at the
posterior edge of the cingulum (slice #1). The second ROI defines trajectories toward
the anterior pole of the temporal lobe (e and f).
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Inferior fronto-occipital fasciculus

Locations of the ROIs for the inferior fronto-occipital fasciculus (ifo) on two coronal
slices (a and c) and their locations in the mid-sagittal slice (b and d). For the coronal
slice in (a), the #2 slice in the previous method for the ilf is used.
Uncinate Fasciculus

Locations of the ROIs for the uncinate fasciculus (unc) on a coronal slice (a and c) and
their locations in the mid-sagittal slice (b and d). The coronal slice (a and c) is the
most posterior slice where the frontal and temporal lobe is separated.
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Forceps Major

Locations of the ROIs for the occipital projection of the corpus callosum (forceps
major) on a coronal slice (a and c) and their locations in an axial slice (b and d). For
the coronal slice in (a) and (b), the #3 slice in the ilf is used.
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Forceps Minor

Locations of the ROIs for the frontal projection of the corpus callosum (forceps minor)
on a sagittal slice (a), a coronal slice (b and d) and their locations in an axial slice (c
and e).
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APPENDIX II: BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) AND
GENE X ENVIRONMENT INTERACTION
Looking into gene x environment interactions of human behavior is on the rise.
There is great variability in behavioral and biological phenotypes than just genetic
factors alone, and these provide clues into the mechanisms modifying genetic risk or
resilience in addiction.

We describe in brief the impact of the Val66Met

polymorphism in alcohol dependence with in this research.
The anatomical information provided by neuroimaging can serve as a
convenient link between anatomical alterations seen in human behavioral differences
and functional genotype. Alone, each approach is limited in its information on gene
function in a complex human disease, but together, a bridge formed links a genotype to
a phenotype.
The BDNF gene and its protein are very versatile and vital for neuronal growth
and development. BDNF is a molecule that is essential for developmental processes
including, neuronal plasticity (Bramham and Messaoudi 2005; Liao et al 2007;
Tongiorgi et al 2006), regulation of both short-term synaptic function and long-term
activity-dependent synaptic consolidation (Thoenen 1995; Katz and Shatz, 1996),
potentiation of synaptic transmission (Lohof et al 1993; Kang and Schuman, 1995;
Levine et al 1995), modulation of long-term potentiation (LTP) in vitro and in vivo
(Patterson et al 1996) and induction of morphological changes in dendritic spines
(McAllister et al 1995). Thus, BDNF has a role in (1) synaptic plasticity; (2) inducing
changes in synaptic morphology; and (3) mediating cell survival and cell proliferation
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during development. These functions serve to underscore the importance of
considering BDNF in any neurodevelopmental disorder of learning.
This research proposed a new direction illustrating the importance of
combining genetics, neuroimaging and behavioral studies to define a role for gene x
environment interaction. One of the aspects included looking at the BDNF and its
impact on behavior and neuroanatomic changes. This line of thought moves us away
from the idea of “risk alleles,” towards recognizing that an allele may be a risk factor
during a period of development and protective factor during another. Specifically, the
Met allele shows decreased secretion, and results in functional deficits in learning
(Egan et al, 2003). The deficit leads to impaired activity dependent release of BDNF
and the expression of the Met allele has been associated with impairment in select
forms of learning and memory (Egan et al, 2003) and susceptibility to psychiatric
disorders (Neves-Pereira et al, 2002; Sklar et al, 2002; Sen et al, 2003; Ribases et al,
2003, 2004). So, the SNP represents the first alteration in a neurotrophin gene that has
been linked to a clinical pathology. As such, the given role of BDNF is promoting
learning and memory (Desai et al, 1999), it may be likely that impaired BDNF
secretion, due to expression of the Met allele, may have pleiotropic effect in all
BDNF-dependent processes and mechanisms.
When BDNF levels peak during adolescence (Katoh-Semba et al, 1997) the
trafficking deficit due to the Met may yield only minor differences in measures.
Therefore, during this period the increased BDNF expression, and the lower secretion
conferred by the Val/Met or Met/Met allele may actually be protective (Gratacos et al,
2007). When BDNF levels are high, carriers of the Val/Val allele may be at greater
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risk for psychiatric disorders given that anxiety, depression, and schizophrenia can
increase BDNF in the amygdala and ventral striatum, areas implicated in bipolar
disorder (Geller et al, 2004) and substance abuse (Matsuhita et al, 2004; Liu, 2005). In
humans, BDNF mRNA levels in cortical regions increase approximately one-third
from infancy to adulthood. They are relatively low during infancy and childhood, peak
during young adulthood, and are maintained at a constant level throughout adulthood.
The increase in BDNF at this critical time in human development may have important
implications for the etiology and treatment of the severe mental disorders that tend to
present during this time (Webster et al 2002). This trafficking deficit may yield only
minor genotypic difference in specific types of learning for the Met allele carriers
during this period of development, and potentially even be protective against other risk
factors (e.g. substance abuse that has been linked to Val allele) (Gratacòs et al., 2007).
The current research provides a new direction for Imaging Genetics and
illustrates the importance of examining a gene by environment interaction focusing on
a single well-defined gene and SNP in collaboration with a single behavioral disease.
We specifically focused on the BDNF gene because of its essential role in synapse
formation, learning and development. Such an approach moves us away from “risk
alleles,” and brings to light the idea that an allele may be protective during one
developmental period and a risk factor during another. For example, with the variant
Val66Met having decreased regulated secretion, we provide preliminary, exploratory
evidence of significant association of level of alcohol dependence and the SNP in
morphologically altered volumes of structures involved in the addiction/reward
pathway. In this case, BDNF levels peak during young adulthood, and may have a
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protective effect on structures in individuals of the Val/Val genotype. Yet, due to a
deficit in trafficking of BDNF, Met allele carriers may have deleterious effects on
neuroanatomical structures.
With the publication of the human genome, researchers continue to uncover the
functions of specific genes. These discoveries will be increased by connecting major
avenues of genetic research across disciplines, using different approaches that bridge
animal models and human psychiatric disorders, to explain gene–environment
interactions across development. Examining how these interactions change during a
developmental time period--a single snapshot in time (Viding et al., 2006) may
provide a valuable new phenotype trajectory rather than genotype alone. Moreover,
such an approach may move psychiatric research closer to preventive strategies for
neurodevelopmental disorders with well-defined endophenotypes.
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APPENDIX III: RAW GRAY MATTER DATA
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APPENDIX IV: RAW WHITE MATTER DATA
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